<SEC-DOCUMENT>0001121404-25-000026.txt : 20251024
<SEC-HEADER>0001121404-25-000026.hdr.sgml : 20251024
<ACCEPTANCE-DATETIME>20251024062033
ACCESSION NUMBER:		0001121404-25-000026
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250930
FILED AS OF DATE:		20251024
DATE AS OF CHANGE:		20251024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31368
		FILM NUMBER:		251414233

	BUSINESS ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kcoverpagepressreleaseq3.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i4bf44a5bede54b0fae80ee7dfabab0ae_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;6-K</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULE&#160;13a-16&#160;OR&#160;15d-16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the month of October 2025</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number&#58;&#160;001-31368</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANOFI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Translation of registrant&#8217;s name into English)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">46, avenue de la Grande Arm&#233;e, 75017 Paris, FRANCE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F&#160;or Form&#160;40-F.</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 20-F&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form&#160;40-F&#160;&#160;&#9744;</font></div><div style="margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2025, Sanofi issued the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:18.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Press release dated October 24, 2025&#58; Q3&#58; continued sales and earnings progress</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.635%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; October 24, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SANOFI</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#47;s&#47; Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Head of Legal Corporate &#38; Finance</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleaseq32025english.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1ad6dd48956a46558d1fbed48fc1ccda_1"></div><div style="min-height:53.86pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.056%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.592%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Press Release</font></div></td><td colspan="3" style="padding:0 1pt;vertical-align:middle"><div style="padding-right:53.86pt;text-align:right"><img alt="fsridynmyoja6nzkxmdjmzjnhza.gif" src="fsridynmyoja6nzkxmdjmzjnhza.gif" style="height:45px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div></td></tr></table></div></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Q3&#58; continued sales and earnings progress</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Paris, October 24, 2025</font></div><div style="margin-bottom:1pt;margin-top:8pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Q3 sales growth of 7.0% at CER</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> and business earnings per share (EPS)</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> of &#8364;2.91</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Pharma launches increased sales by 57.1%, reaching &#8364;1.0 billion, driven by ALTUVIIIO and Ayvakit</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Dupixent sales increased by 26.2% to &#8364;4.2 billion, first time above &#8364;4 billion in a quarter</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Vaccines sales decreased by 7.8% to &#8364;3.4 billion, from lower influenza sales</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Research and Development expenses were &#8364;1.8 billion, an increase of 4.9%</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Selling, general and administrative expenses were &#8364;2.3 billion, up 7.1% to support launches</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Business EPS was &#8364;2.91, up 13.2% at CER and 7.0% at actual exchange rates, delivering profitable growth&#59; IFRS EPS was &#8364;2.30</font></div><div style="margin-bottom:1pt;margin-top:8pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pipeline progress</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Two regulatory approvals&#58; Wayrilz (US) in ITP, a rare disease, and Tzield (China) for delaying onset of stage 3, type 1 diabetes</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Two positive phase 3 readouts&#58; amlitelimab&#8217;s first phase 3 study in atopic dermatitis and Fluzone HD in influenza 50+ years</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Eight regulatory submission acceptances, three phase 3 study starts, and three regulatory designations (fast track, orphan)</font></div><div style="margin-bottom:1pt;margin-top:8pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Capital allocation</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:line-through">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Completion of the Vigil Neuroscience acquisition, adding to the early-stage pipeline</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Additional commitment of $625 million to Sanofi Ventures, investing in innovative biotech and digital health companies</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:line-through">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Sanofi intends to complete its &#8364;5 billion share buyback program in 2025. 86.1% has been executed to date</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sustainability</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Global Health Unit&#58; one million patients have now received treatments for non-communicable diseases since 2021</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Insulins Val</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">you</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Savings Program&#58; improving access to reliable and affordable supply of critical medicines in the US</font></div><div style="margin-bottom:1pt;margin-top:8pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guidance unchanged</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">In 2025, sales are anticipated to grow by a high single-digit percentage at CER. Sanofi confirms the expectation of a strong business EPS rebound with growth at a low double-digit percentage at CER (before share buyback)</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">3</font></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><font style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Paul Hudson, Chief Executive Officer&#58;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#8220;We continued executing on our strategy and the growth momentum continued in Q3 with sales up by 7.0% over a high base of comparison last year. Newly launched medicines and vaccines grew by 40.8%. Dupixent grew by 26.2% and exceeded for the first time both four billion euros in quarterly global sales and three billion euros in the US, despite an unfavorable currency impact. As expected, our flu vaccines business declined because of increased price competition and lower vaccination rate. Business EPS increased by 13.2%, supported by disciplined spending, R&#38;D prioritization, and operational efficiency. After three quarters of profitable growth, we reiterate our 2025 guidance.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Our strategic focus on science, patients, and pipeline delivered important milestones in the quarter, including positive phase 3 data for amlitelimab in atopic dermatitis with all primary and key secondary endpoints met, increasing efficacy over time, and a patient-friendly quarterly dosing. We obtained two regulatory approvals&#58; Wayrilz in the US for the rare disease immune thrombocytopenia and Tzield in China to delay the onset of stage 3, type 1 diabetes. We submitted eight regulatory applications, initiated three new phase 3 studies, and received three new regulatory designations.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">The acquisition of Vigil Neuroscience closed in August, and we will complete our share buyback program by the end of the year. Sanofi will strategically deploy capital towards growth and differentiated science with expected attractive financial returns. As we are looking forward to 2026, we are confident in our ability to pursue our current trajectory of profitable growth.&#8221;</font></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_4"></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:24.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IFRS net sales reported</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;12,434&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.3</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.0</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;32,323&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.9</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IFRS net income reported</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;2,802&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,614&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+70.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IFRS EPS reported</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;2.30&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;7.04&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+73.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Free cash flow<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">4</font></font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;2,994&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.1</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;5,452&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+50.8</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business operating income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;4,445&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;9,808&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;3,547&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;7,699&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business EPS</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;2.91&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.0</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+13.2</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;6.30&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.4</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.4</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Changes in net sales are at constant exchange rates (CER) unless stated otherwise (definition in Appendix 9).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> To facilitate an understanding of operational performance, Sanofi comments on the business net income, a non-IFRS financial measure (definition in </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Appendix 9). The income statement is in Appendix 3 and a reconciliation of net income as reported under IFRS to business net income is in Appendix 4.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Applying October 2025 average currency exchange rates, the currency impacts are estimated at c.-4% on sales and at c.-6% on business EPS.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Free cash flow is a non-IFRS financial measure (definition in Appendix 9).</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">1</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_7"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Q3 and YTD 2025 summary</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A conference call and webcast for investors and analysts will begin at 14&#58;30 CEST with details on sanofi.com, including slides.</font></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.332%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #7802e6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">The performance shown in this press release covers the three-month period to September 30, 2025 (the quarter or Q3 2025) and the nine-month period to September 30, 2025 (the year to date or YTD 2025) compared to the three-month period to September 30, 2024 (Q3 2024) and the nine-month period to September 30, 2024 (YTD 2024) respectively. All percentage changes in sales in this press release are at CER.</font></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.332%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #7802e6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Q3 2025, sales were &#8364;12,434 million and increased by 7.0%. Exchange rate movements had a negative effect of 4.7&#160;percentage points (pp)&#59; therefore, at actual exchange rates, sales increased by 2.3%. The divestments of medicines&#47;portfolio streamlining had a negative impact of 0.3pp on sales growth. In YTD 2025, sales were &#8364;32,323 million and increased by 8.7%. Exchange rate movements had a negative effect of 2.8pp&#59; therefore, at actual exchange rates, sales increased by 5.9%. The divestments of medicines&#47;portfolio streamlining had a negative impact of 0.4pp on sales growth.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales by geography</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,838&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.1</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,373&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.1</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,589&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,733&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rest of World</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,007&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,217&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which China</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">689&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.7</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,077&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+0.9&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:115%">US</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">sales were &#8364;6,838 million and increased by 11.1%. The performance was primarily driven by Immunology, pharma launches, and Lantus, partly offset by Vaccines.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Europe</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;2,589 million and increased by 2.8%. Growth was primarily driven by Beyfortus, Immunology, and pharma launches. Sales of some legacy medicines and influenza vaccines were lower.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;3,007 million and increased by 1.9%. The performance was led by Immunology, Beyfortus, and pharma launches, while many legacy medicines and vaccines declined. </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">China</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;689 million and increased by 2.7% in a slightly declining market, impacted by the renewed national reimbursement drug list and volume-based procurement.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business operating income</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Q3 2025, business operating income (BOI) was &#8364;4,445 million and increased by 8.5% (2.7% at actual exchange rates) from &#8364;4,327 million in Q3 2024. The ratio of BOI to net sales was 36.1% and increased by 0.5pp (35.7% at actual exchange rates, up by 0.1pp). The increase was mainly driven by higher business gross profit (up by 10.6%) and modest growth in R&#38;D expenses (up by 4.9%), partly offset by higher Regeneron profit sharing. In YTD 2025, BOI was &#8364;9,808 million and increased by 9.7% (5.9% at actual exchange rates) from 9,265 million in YTD 2024. The ratio of BOI to net sales was 30.6% and increased by 0.2pp (30.3% at actual exchange rates, down by 0.1pp).</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business development</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business development, including strategic investments in external innovation is an integral part of Sanofi&#8217;s efforts to access optionality for promising scientific developments to contribute to pipeline replenishment.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi announced an additional $625 million multi-year capital commitment to Sanofi Ventures, increasing the total assets under management to over $1.4 billion. This new commitment to the evergreen venture fund builds on more than a decade of investing in innovative biotech and digital health companies that align with Sanofi&#8217;s long-term growth ambitions. Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in top-tier biotech and artificial intelligence&#47;digital health companies that focus on helping patients and transforming the practice of medicine. Since its inception in 2012, the fund has deployed over $800 million across more than 70 innovative companies in biotech and digital health.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi announced the completion of its $470 million acquisition of Vigil Neuroscience, Inc. (Vigil). This acquisition strengthens Sanofi&#8217;s early-stage pipeline in neurology with VG-3927, a novel, oral, small-molecule TREM2 agonist targeting Alzheimer&#8217;s disease. In addition, the acquisition of Vigil&#8217;s preclinical pipeline will further strengthen Sanofi&#8217;s research in various neurodegenerative diseases. In June 2024, Sanofi Capital made a $40 million strategic investment in Vigil that included the exclusive right of first negotiation for an exclusive license, grant, or transfer of rights to research, develop, manufacture, and commercialize VG-3927.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_10"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Biopharma segment</font></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_13"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pharma</font></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_16"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Launches</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ALTUVIIIO</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">294&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+81.4</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">836&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+90.0</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadyme</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+27.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">587&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Sarclisa</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+41.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">431&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+28.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Ayvakit</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Rezurock</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Cablivi</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">202&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Xenpozyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+43.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+50.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Tzield</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Qfitlia</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Wayrilz</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,046</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+57.1</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,790</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+47.2</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">ALTUVIIIO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (hemophilia A) sales were &#8364;294 million of which 84% was in the US. Growth was driven by continued patient switches from older, short half-life and extended half-life factor medicines, from Eloctate, and from non-factor treatments. Rest of World sales of &#8364;47 million benefited from the launches in Japan and Taiwan, and supply sales to the collaborator Sobi. The hemophilia A franchise (ALTUVIIIO and Eloctate combined) sales were &#8364;371 million and increased by 47.0%, primarily driven by ALTUVIIIO&#8217;s strong performance of &#8364;294 million, while Eloctate contributed &#8364;77 million.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Nexviazyme&#47;Nexviadyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Pompe disease) sales were &#8364;200 million and increased by 27.6%, driven by Europe (+57.4%). In the US (+15.6%), most patients have switched from Myozyme&#47;Lumizyme. The Pompe disease franchise (Nexviazyme&#47;Nexviadyme and Myozyme&#47;Lumizyme combined) sales were &#8364;322 million and increased by 0.9%.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Sarclisa</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (multiple myeloma) sales were &#8364;155 million and increased by 41.2%, supported by high growth in all regions and driven by increased use in the front-line combination treatment setting.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Rezurock</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (chronic graft-versus-host disease, third line) sales were &#8364;114 million and decreased by 6.9%. Sales in the US decreased by 9.3% due to mandatory rebates, and sales in Europe were -&#8364;1 million from a one-time reimbursement. In Rest of World, sales were &#8364;15 million, the overwhelming majority in China.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Ayvakit</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (mastocytosis) sales were &#8364;137 million. Ayvakit was consolidated by Sanofi from mid-July following the acquisition of Blueprint Medicines Corporation (Blueprint). Sales were split across the US (&#8364;119 million), Europe (&#8364;16 million), and Rest of World (&#8364;2 million) and performed in line with expectations with a large opportunity to increase penetration rates in all geographies.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cablivi</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (acquired thrombotic thrombocytopenic purpura) sales were &#8364;66 million and increased by 9.5%, driven by more patients being identified for treatment in the US and Europe and lower use of the US access program.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Xenpozyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (acid sphingomyelinase deficiency) sales were &#8364;57 million and increased by 43.9%, mainly driven by Europe (+57.1%) and Rest of World (+71.4%).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Tzield</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (delay onset of type 1 diabetes) sales were &#8364;18 million (of which &#8364;17 million in the US) and increased by 26.7% with sales reflecting improved momentum in infusions benefiting from the continued investment in education about autoimmune type 1 diabetes and progress in screening.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Qfitlia</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (hemophilia A and B) sales were &#8364;4 million, all in the US, with more patients being treated following approval in March.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Wayrilz</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (immune thrombocytopenia) sales were &#8364;1 million, all in the US, following approval in August.</font></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_19"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Immunology</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,156&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.2</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,468&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+22.7</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Dupixent</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;4,156 million and increased by 26.2%. For the first time, global sales exceeded four billion euros in a quarter and were driven by strong demand in all approved indications (atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis, chronic spontaneous urticaria, chronic obstructive pulmonary disease (COPD), bullous pemphigoid (BP)). In the US sales were &#8364;3,073 million and increased by 27.9% driven by volume growth in all approved indications. For the first time, US sales exceeded three billion euros in a quarter. In Europe, sales were &#8364;504 million and increased by 20.9% also reflecting volume growth in all approved indications. In Rest of World, sales were &#8364;579 million and increased by 21.7%, mainly driven by Brazil and Asia&#47;Pacific, partially offset by the impact of the national reimbursement drug list renewal in China in January. In YTD 2025, sales were &#8364;11,468 million and increased by 22.7%, driven by strong demand across all indications and geographies.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_22"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other main medicines</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">438&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.7</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,314&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+13.7</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Toujeo</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">321&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,013&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Fabrazyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">242&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">767&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">223&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">696&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">196&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">643&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Cerezyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">161&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">524&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Alprolix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">394&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Myozyme&#47;Lumizyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-24.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">366&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">252&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-24.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-44.6</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-36.5</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Lantus</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;438 million and increased by 6.7%. US sales were &#8364;214 million and increased by 29.7% benefiting from gross-to-net adjustments and an element of windfall sales due to the unavailability of competing medicines. Customer demand is now expected to normalize in 2026. In Europe and Rest of World, combined sales decreased by 9.0%, reflecting growth of Toujeo.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Toujeo</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;321 million and increased by 9.2%, driven by Rest of World (+13.7%) where Toujeo continued to increase its basal insulin market share. Sales in Europe (+5.1%) and US (+7.4%) also increased.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Fabrazyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;242 million and broadly stable (-0.4%) with a slight growth in the number of patients outside the US.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Plavix</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;223 million and increased by 1.3%, reflecting volume growth in Rest of World (majority of sales, &#8364;200 million), including from volume-based procurement in China.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Lovenox</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;196 million and decreased by 14.6%, impacted by biosimilar competition in Europe.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cerezyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;161 million and broadly stable (+0.6%), with a slight growth in the number of patients. The Gaucher disease franchise (Cerezyme and Cerdelga) sales were &#8364;247 million and increased by 4.1%.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Alprolix</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;149 million and increased by 7.4%, driven by supply sales to the collaborator Sobi.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Praluent</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;127 million and increased by 1.6% from higher sales in Europe offset by lower sales in Rest of World.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Myozyme&#47;Lumizyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;122 million and decreased by 25.0% as patients switch to Nexviazyme&#47;Nexviadyme.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Thymoglobulin</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;118 million and increased by 3.3%, reflecting higher sales in the US and Rest of World.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cerdelga</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;86 million and increased by 11.1% from growth in the number of patients.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Eloctate</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;77 million and decreased by 14.6% as patients switch to ALTUVIIIO.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Aubagio</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;49 million and decreased by 44.6% from loss of exclusivity in 2023. Aubagio sales will decrease further.</font></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_25"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vaccines</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Influenza, COVID-19</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,525&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-16.8</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,739&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.9</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beyfortus</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">739&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,095&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Polio&#47;Pertussis&#47;Hib primary and booster vaccines</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,003&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-2.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Meningitis, travel, and endemic</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">451&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,060&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,357</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-7.8</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,897</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-0.7</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;3,357 million and decreased by 7.8%, driven by lower sales of influenza vaccines.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Influenza, COVID-19 vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;1,525 million and decreased by 16.8%, in line with the full-year expectation. Sales in Europe (-25.6%) were impacted by competitive price pressure, mainly in Germany while sales in the US (-11.4%) were also impacted by a lower vaccination rate early in the season.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Beyfortus</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;739 million and increased by 19.8%. Sales in Europe (+166.3%) and Rest of World (+526.7%) were driven by geographical roll-out of infant protection&#59; Beyfortus now protects infants in more than 40 countries. Sales in the US (-21.4%) were reduced by a high comparison and existing inventory levels at the beginning of the season.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Polio&#47;Pertussis&#47;Hib (PPH) primary and booster vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;642 million and decreased by 12.2%, reduced by delivery phasing earlier in the year of primary vaccine sales in some public markets.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Meningitis, travel, and endemic vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;451 million, and decreased by 1.9%, driven by lower sales of meningitis vaccines in all geographies partly offset by higher sales of travel vaccines.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">4</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_28"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business operating income</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Q3 2025, Biopharma BOI was &#8364;4,438 million and increased by 8.3% (2.5% at actual exchange rates) from &#8364;4,331 million in Q3 2024. The ratio of BOI to net sales was 36.0% and increased by 0.4pp (35.7% at actual exchange rates, up by 0.1pp). The increase was mainly driven by higher business gross profit (up by 10.1%) and modest growth in R&#38;D expenses (up by 4.9%), partly offset by higher Regeneron profit sharing. In YTD 2025, Biopharma BOI was &#8364;9,785 million and increased by 9.7% (5.8% at actual exchange rates) from &#8364;9,247 million in YTD 2024. The ratio of BOI to net sales was 30.6% and increased by 0.3pp (30.3% at actual exchange rates, stable).</font></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_31"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pipeline update</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has 94 projects in a pipeline across four main disease areas (Immunology, Rare diseases, Neurology, and selectively in Oncology) and Vaccines, including 44 potential new medicines and vaccines. The following section highlights significant developments in the late- and mid-stage pipeline since the prior results press release.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Highlights</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:31.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.389%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Regulatory approvals</font></td><td colspan="3" style="border-left:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wayrilz &#8211; ITP (US)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield &#8211; T1D, stage 2, delay onset of stage 3 (CN)</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Regulatory submission acceptances</font></td><td colspan="3" style="border-left:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent &#8211; CSU children (US, EU)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield &#8211; T1D, stage 3, delay progression (US, CNPV review)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wayrilz &#8211; ITP (JP)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sarclisa &#8211; subcutaneous (US, EU, JP, CN)</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase 3 data readouts</font></td><td colspan="3" style="border-left:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">amlitelimab &#8211; AD (COAST 1) &#8211; primary endpoints met</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fluzone HD &#8211; influenza 50 years+ &#8211; primary endpoint met</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase 3 study starts</font></td><td colspan="3" style="border-left:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">lunsekimig &#8211; COPD (PERSEPHONE)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wayrilz &#8211; SCD, wAIHA</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000;border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Regulatory designations</font></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-left:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wayrilz &#8211; IgG4-RD orphan (EU)<br>SAR446268 &#8211; DM1 fast track (US)<br>SAR402663 &#8211; wet AMD fast track (US)</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Immunology</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dupixent</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (dupilumab)</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:line-through">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The European Medicines Agency (EMA)&#8217;s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of Dupixent in the EU for the treatment of </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">chronic</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">spontaneous</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">urticaria</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (CSU) in adults and adolescents. This recommendation covers those aged 12 years and above with moderate to severe disease, with inadequate response to histamine-1 antihistamines, and who are naive to anti-immunoglobulin E therapy. A final decision is expected in the coming months. Dupixent is approved for CSU in certain adults and adolescents in several countries including Japan and the US.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The US Food and Drug Administration (FDA) accepted for review the regulatory submission of the supplemental biologics license application (sBLA) for Dupixent to treat </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">CSU</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in children. The target action date for the FDA decision is April 27, 2026. A regulatory submission was also accepted in the EU.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rezurock</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (belumosudil)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The CHMP issued a negative opinion on the marketing authorisation application of Rezurock for the third-line treatment of adults and children with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">chronic</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">graft-versus-host</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">disease</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (cGVHD). Sanofi will seek a re-examination of the CHMP opinion. cGVHD is a life-threatening complication that devastates the lives of up to 50% of patients who undergo a stem cell transplant. cGVHD is considered one of the main causes of morbidity and late non-relapse mortality after stem cell transplant.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tzield</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (teplizumab)</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The Chinese National Medical Products Administration (NMPA) approved Tzield as the first disease-modifying therapy in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">autoimmune</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">type</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">diabetes</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (T1D) indicated to delay the onset of stage 3 T1D in adult and children aged eight years and older with stage 2 T1D. The review was completed under priority review, following the recognition by NMPA of Tzield&#8217;s innovative profile and the benefit it brings to children. Tzield is approved for the treatment of adults and children aged eight years and older, living with stage 2 T1D, in the US, with regulatory reviews ongoing in the EU.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The FDA accepted for expedited review the sBLA for Tzield to delay the progression of stage 3 T1D in adults and children eight years of age and older recently diagnosed with stage 3 T1D. The FDA nominated Tzield for the Commissioner's National Priority Voucher (CNPV) pilot program based on its potential to address a large unmet medical need. The CNPV program aims to shorten the review process from what normally takes 10-12 months to 1-2 months, while maintaining FDA's rigorous safety and efficacy standards. Tzield had previously been granted priority review for the sBLA.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">amlitelimab</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (OX40L mAb)</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:line-through">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Positive results from the global COAST 1 phase 3 study (clinical study identifier&#58; NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody (mAb) that targets OX40-ligand (OX40L), dosed either every four weeks (Q4W) or every 12 weeks (Q12W), met all primary and key secondary endpoints, demonstrating statistically significant and clinically meaningful skin clearance and disease severity compared to placebo at Week 24 in patients aged 12 years and older with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">moderate-to-severe</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">atopic</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">dermatitis</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (AD). Amlitelimab was well-tolerated, with no new safety concerns identified in this study.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">5</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">For US and US reference countries, the primary endpoint was the proportion of patients with a validated investigator global assessment for AD (vIGA-AD) of 0 (clear) or 1 (almost clear) and a reduction from baseline score of &#8805;2 points. For the EU, EU reference countries and Japan, the co-primary endpoints comprised the proportion of patients with vIGA-AD 0&#47;1 and a reduction from baseline score of &#8805;2 points along with the proportion of patients reaching a 75% or greater improvement in the eczema area and severity index total score (EASI-75). In both treatment arms, a progressive increase in efficacy without plateau was observed during the treatment period. The study&#8217;s key secondary endpoints were also achieved across both dosing arms at Week 24.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The OCEANA clinical development program of amlitelimab in AD, which includes COAST 1 and four other phase 3 studies (SHORE, COAST 2, AQUA, and ESTUARY) is anticipated to read out through 2026 and comprises the foundation for potential global regulatory submissions.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">At the European Respiratory Society International Congress in Amsterdam, Netherlands, exploratory efficacy data from the TIDE-Asthma phase 2 study (clinical study identifier&#58; NCT05421598) in patients with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">moderate-to-severe</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">asthma</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were presented. While the primary endpoint of annualized asthma exacerbation rate (AAER) reduction at Week 48 did not reach statistical significance at the 250 mg dose, notable improvements were observed across key secondary endpoints, including pre-bronchodilator forced expiratory volume in one second (pre-BD FEV&#8321;) and improvements in asthma control questionnaire (ACQ-5) scores. In a post-hoc analysis, patients with potential evidence of mixed-type inflammation based on elevated blood neutrophils (&#8805;4000 cells&#47;&#181;L) and eosinophils (&#8805;300 cells&#47;&#181;L) showed the greatest benefit with amlitelimab, including greater reductions in AAER, and larger improvements in pre-BD FEV&#8321; and ACQ-5 scores. Amlitelimab was well-tolerated, with no new safety concerns identified in this study.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">lunsekimig</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (IL13xTSLP Nanobody&#174; VHH)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Two proof-of-concept phase 2b&#47;3 studies of two dosing intervals of subcutaneous lunsekimig compared with placebo commenced dosing the first patient in the </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">COPD</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> program&#59; PERSEPHONE (clinical study identifier&#58; NCT07190209) and THESEUS (clinical study identifier&#58; NCT07190222).</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">brivekimig</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (TNFxOX4OL Nanobody&#174; VHH)</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:line-through">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">At the European Academy of Dermatology and Venereology Congress in Paris, France, data from the HS-OBTAIN phase 2a study (clinical study identifier&#58; NCT05849922) was presented. The HS-OBTAIN phase 2a study is a randomized, double-blind, placebo-controlled, proof-of-concept study assessing the efficacy and safety of brivekimig in adults with moderate-to-severe </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">hidradenitis</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">suppurativa</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (HS). The data showed that treatment with subcutaneous brivekimig 150 mg every two weeks led to clinically meaningful improvements in the primary endpoint of Hidradenitis Suppurativa Clinical Response (HiSCR50) in patients na&#239;ve to biologics with moderate-to-severe hidradenitis suppurativa. Brivekimig was well tolerated, with no serious adverse events. HS is a chronic and debilitating inflammatory skin disease characterized by painful cutaneous nodules, abscesses and draining tunnels. For example, approximately 196,000 adults in the EU live with HS.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The randomized, double-blind, placebo-controlled, dose-ranging BRIGHTEN phase 2b study (clinical study identifier&#58; NCT07170917) of brivekimig in patients with moderate-to-severe HS will commence soon.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Two proof-of-concept phase 2 studies of different dose regimens of subcutaneous brivekimig compared with placebo commenced dosing the first patients in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Crohn&#8217;s</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">disease</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (clinical study identifier&#58; NCT06958536) and </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">ulcerative</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">colitis</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (UC) (clinical study identifier&#58; NCT06975722).</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">balinatunfib</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (oral anti-TNF)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">During the quarter, data from a phase 2 study (clinical study identifier&#58; NCT06073093) of balinatunfib in patients with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">rheumatoid</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">arthritis</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (RA) not adequately controlled with methotrexate (MTX) and naive to advanced treatments finished its analysis. The study assessed the safety and efficacy of balinatunfib at four dose schedules against placebo on a background of MTX standard treatment using established RA endpoints. The primary endpoint assessment using ACR20 did not achieve statistical significance due to a very high placebo response of more than 50%. However, when assessing endpoints requiring deeper disease control, including ACR50, ACR70, and low-disease activity DAS28-CRP&#8804;3.2, the efficacy signal was clinically meaningful. Balinatunfib was generally well tolerated over the short treatment period of 12 weeks and the safety profile was consistent with prior studies. The future development strategy for balinatunfib is currently being evaluated, including the potential to become a combination backbone for internal as well as externally partnered oral medicines for the treatment of RA and other diseases in which TNF plays a key role in the pathophysiology of the disease.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Rare diseases</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Wayrilz </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(rilzabrutinib)</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The FDA approved Wayrilz for adults with persistent or chronic </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">immune</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">thrombocytopenia</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (ITP) who have had an insufficient response to a previous treatment. The approval was based on the pivotal LUNA 3 phase 3 study, in which Wayrilz met the primary and secondary endpoints, showing a positive impact on sustained platelet counts and other ITP symptoms. As a novel, oral, reversible, Bruton&#8217;s tyrosine kinase inhibitor, Wayrilz can help address the root causes of ITP through multi-immune modulation, targeting different pathways across the immune system. Wayrilz is currently under regulatory review for ITP in the EU, Japan (submitted during the quarter), and China.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The CHMP adopted a positive opinion recommending the approval of Wayrilz as a new treatment for ITP in adult patients who are refractory to other treatments. A final decision is expected in the coming months.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%;text-decoration:line-through">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The EMA granted orphan designation to Wayrilz for </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">IgG4-related</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">disease</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (IgG4-RD). EMA grants orphan designation to potential new medicines addressing rare, life-threatening, or debilitating diseases or conditions that affect no more than 5 in 10,000 persons in the EU. In addition to IgG4-RD, Wayrilz has received orphan designations for ITP in the US, the EU, and </font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">6</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Japan&#59; and for warm autoimmune hemolytic anemia (wAIHA), IgG4-RD, and sickle cell disease (SCD) in the US. Wayrilz has also been granted fast track designation in the US in ITP and IgG4-RD.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Two phase 3 studies of Wayrilz commenced dosing the first patients in rare diseases. One study will assess the medicine in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">SCD</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, LIBRA (clinical study identifier&#58; NCT06975865) and one study in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">wAIHA</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, LUMINA 3 (clinical study identifier&#58; NCT07086976).</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A proof-of-concept phase 2 study (clinical study identifier&#58; NCT06984627) of two dose regimens of Wayrilz in patients with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Graves'</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">disease</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> commenced dosing the first patient. Graves' disease, also known as toxic diffuse goiter or Basedow's disease, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results in an enlarged thyroid.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SAR447537</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (efdoralprin alfa)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Positive results from the global ElevAATe phase 2 study (clinical study identifier&#58; NCT05856331) showed that efdoralprin alfa (formerly known as INBRX-101), met all primary and key secondary endpoints when dosed every three weeks (Q3W) or four weeks (Q4W) in adults with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">alpha-1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">antitrypsin</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">deficiency</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (AATD) emphysema, a rare disease. Efdoralprin alfa is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein. It demonstrated a statistically significant greater mean increase in functional AAT levels within normal range as measured by trough concentrations at steady state compared to those receiving weekly plasma-derived augmentation therapy at Week 32 &#91;p&#60;0.0001&#93;. The study also met key secondary endpoints, demonstrating superior mean increase in fAAT average concentration as well as higher percentage of days above the lower limit of the normal range for both Q3W and Q4W dosing. Efdoralprin alfa was well tolerated with a similar adverse event profile to plasma-derived therapy. Additional safety follow-up is being assessed in the ElevAATe OLE phase 2 study (clinical study identifier&#58; NCT05897424). Efdoralprin alfa was previously granted fast track and orphan drug designation by FDA for the treatment of AATD emphysema. Sanofi plans to present the data at a forthcoming medical meeting and engage with global regulatory authorities on the appropriate next steps.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SAR446268</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (DMPK-silencing gene therapy)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA granted fast-track designation to SAR446268, a one-time gene therapy for the treatment of </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">non-congenital</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">(juvenile</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">and</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">adult</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">onset)</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">myotonic</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">dystrophy</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">type</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (DM1), long known as Steinert disease. SAR446268 is the only potential new gene therapy in clinical development for this disease, and there are no currently approved treatments for DM1. SAR446268 is expected to advance into a first-in-human, phase 1&#47;2 study (clinical study identifier&#58; NCT06844214) in late 2025. Sanofi has already been granted orphan designations for SAR446268 in both the US (July 2024) and EU (October 2024).</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Neurology</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">tolebrutinib</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (BTK inhibitor)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA extended by three months the target action date of its review of the new drug application (NDA) of tolebrutinib to treat non-relapsing </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">secondary</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">progressive</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">multiple</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">sclerosis</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (SPMS) and to slow disability accumulation independent of relapse activity in adult patients. Based on the submission of additional analyses during the review, the FDA determined that the additional information constituted a major amendment to the NDA and extended the target action date accordingly. The revised target action date for the FDA decision is December 28, 2025. In addition to the extended regulatory review in the US, tolebrutinib is being reviewed by other regulatory agencies, including in the EU. As part of the ongoing regulatory dialogue to establish the appropriate benefit&#47;risk profile of tolebrutinib, agencies are focused on the target patient population, comparing efficacy across populations, and the proposed safety risk mitigation plan to address liver toxicity.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SAR402663</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (FLT01-encoding gene therapy)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA granted fast-track designation to SAR402663, a one-time, intravitreal gene therapy for the treatment of neovascular (or &#8216;wet&#8217;) </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">age-related</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">macular</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">degeneration</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (AMD). SAR402663 is currently in a phase 1&#47;2 study (clinical study identifier&#58; NCT06660667).</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Oncology</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarclisa</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (isatuximab)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA accepted for review the regulatory submission of the sBLA for subcutaneous Sarclisa in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">multiple</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">myeloma</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. The target action date for the FDA decision is April 23, 2026. Regulatory submissions were also completed in the EU, Japan, and China.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SAR447873</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">212</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Pb-dotamtate)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">At the 2025 European Society for Medical Oncology Congress, Berlin, Germany, positive data from the ALPHAMEDIX-02 phase 2 study (clinical study identifier&#58; NCT05153772) showed that SAR447873, a somatostatin receptor (SSTR)-targeted alpha therapy using the lead-212 isotope, met all primary efficacy endpoints and showed clinically meaningful overall response rates and prolonged clinical benefits in both peptide receptor radionuclide therapy (PRRT)-na&#239;ve and PRRT-exposed patients with unresectable or metastatic SSTR-positive </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">gastroenteropancreatic</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">neuroendocrine</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">tumors</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (GEP-NETs). Benefits in key secondary endpoints, including progression-free survival and overall survival, were also observed across both cohorts. SAR447873 had a manageable safety profile that was similar across both cohorts. In February 2024, the medicine was designated a breakthrough therapy by the FDA for treatment of PRRT-na&#239;ve patients with unresectable or metastatic, progressive SSTR-expressing GEP-NETs. Next steps for SAR447873 will be decided following discussions with health authorities.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Vaccines</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Efluelda </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(influenza)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">New data from the FLUNITY-HD phase 4 study (clinical study identifier&#58; NCT06506812), published in </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">The</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Lancet</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, demonstrated that Efluelda (Fluzone High-Dose in North America) significantly reduced the risk of hospitalizations in adults 65 years and older compared to standard-dose </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">influenza</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. This was the largest influenza vaccine effectiveness study of individually randomized older adults, involving nearly half a million participants across multiple seasons and two geographic areas. This study provided robust evidence that the high-dose influenza vaccine offers superior protection against the severe complications of influenza, including&#58;</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">- 31.9% (95% CI, 19.7 to 42.2&#59; p&#60;0.001) additional reduction in lab-confirmed influenza hospitalizations</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">- 8.8% (95% CI, 1.7 to 15.5&#59; p&#61;0.008) additional protection against pneumonia&#47;influenza hospitalizations</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">- 6.3% (95% CI, 2.5 to 10.0&#59; p&#60;0.001) additional reduction in hospitalizations for cardio-respiratory events</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">- 2.2% (95% CI, 0.3 to 4.1&#59; p&#61;0.012) additional protection against all-cause hospitalizations, meaning one additional hospitalization could be averted for every 515 (95% CI, 278 to 3,929) individuals vaccinated with Efluelda instead of a standard-dose flu vaccine.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nuvaxovid </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(COVID-19)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In October, Novavax announced that it had completed the transfer of the EU marketing authorisation for Nuvaxovid in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">COVID-19</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> prevention to Sanofi, enabling Sanofi to take control of commercial and regulatory activities. The marketing authorization transfer in the US is ongoing.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fluzone HD </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(influenza 50 years+)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Fluzone High-Dose (HD) &#47; Efluelda is approved in many jurisdictions (including the US and EU) to prevent </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">influenza</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> in people aged 65 years and above. A phase 3 study (clinical study identifier&#58; NCT06641180) in people aged 50 to 64 years read out positively on safety and immunogenicity at an interim analysis, supporting planned regulatory submissions in 2026 for a potential label extension down to adults aged 50 years and older.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0125 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(RSV toddler)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The SP0125 program for the prevention of </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">respiratory</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">syncytial</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">virus</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (RSV)-related disease in toddlers was recently discontinued following a planned futility analysis conducted by an independent data monitoring committee (IDMC). The decision was due to insufficient efficacy seen in the main PEARL phase 3 study (clinical study identifier&#58; NCT06252285). The safety profile was acceptable, and no signals of vaccine-associated enhanced respiratory disease were observed by the IDMC.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0287 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(Fluzone HD&#47;Flublok and Nuvaxovid)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The SP0287 program consists of two combination vaccine candidates&#58;  the inactivated </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">influenza</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> vaccine Fluzone HD or the recombinant-protein influenza vaccine Flublok and the adjuvanted recombinant </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">COVID-19</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> vaccine Nuvaxovid. The phase 1&#47;2 study of each combination (clinical study identifiers&#58; NCT06695117 and NCT06695130) completed with preliminary positive safety and immunogenicity results. Sanofi will engage with regulatory authorities to discuss next step for this program.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0289 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(influenza, H5 pandemic, mRNA)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The phase 1&#47;2 study (clinical study identifier&#58; NCT06744205) of the SP0289 vaccine candidate to prevent </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">H5</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">pandemic</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">influenza</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> showed a good safety profile and strong immunogenicity results, with 90-100% of people achieving seroprotection after two doses across all formulations tested. Sanofi is evaluating the next steps for this program.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0335 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(influenza, H5 pandemic, inactivated adjuvanted)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In September, Novavax announced that it had expanded Sanofi's license to include use of Novavax's Matrix-M adjuvant with SP0335, a second vaccine candidate to prevent </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">H5</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">pandemic</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">influenza</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Sanofi received funding from the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services in the US, for early-stage clinical work on this vaccine candidate including the Matrix-M adjuvant.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Anticipated major upcoming pipeline milestones</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:9.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Medicine&#47;vaccine</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Indication</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="11" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2025</font></td><td colspan="3" rowspan="2" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">CSU</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">allergic fungal rhinosinusitis</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (US)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">teplizumab</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">T1D, stage 2, delay onset of stage 3</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">T1D, stage 3, delay progression</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wayrilz</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ITP</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Qfitlia</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">hemophilia A&#47;B</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (CN)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">tolebrutinib</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SPMS</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">primary progressive multiple sclerosis (PPMS)</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SP0087</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">rabies</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (US, EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SP0230</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">meningitis</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SP0256</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RSV older adults</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 2 data</font></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> The standard-dose influenza vaccines used in the FLUNITY-HD study were VaxigripTetra (Sanofi) and InfluvacTetra (a registered trademark of Viatris). </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Standard-dose vaccines often serve as the primary influenza prevention option for the general population.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">8</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:9.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.715%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="16" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">H1 2026</font></td><td colspan="3" rowspan="2" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BP</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (EU, JP, CN)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">CSU children</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (US, EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">amlitelimab</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AD</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 3 data (full readout)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">lunsekimig</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">asthma</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">eclitasertib</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">UC</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">T1D, stage 3, delay progression</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gaucher disease type 3 (GD3)</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nexviazyme</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">infantile-onset Pompe disease (IOPD)</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="4" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">venglustat</font></td><td colspan="3" rowspan="2" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabry disease</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (US)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">GD3</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sarclisa</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">subcutaneous</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (US, EU, JP)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">tolebrutinib</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SPMS</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">PPMS</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (US, EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fluzone HD</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">influenza 50 years+</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (US)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="7" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">H2 2026</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">lichen simplex chronicus</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">amlitelimab</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AD</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wayrilz</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ITP</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory decision (JP, CN)</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nexviazyme</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IOPD</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">efdoralprin alfa</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AATD emphysema</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fluzone HD</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">influenza 50 years+</font></div></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">regulatory submission (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SP0218</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">yellow fever</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">phase 3 data</font></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">A status on the Sanofi pipeline as of September 30, 2025, is available at&#58; https&#58;&#47;&#47;www.sanofi.com&#47;en&#47;our-science&#47;our-pipeline.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">9</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_34"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Sustainability update</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Access to healthcare</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Global Health Unit in LMICs</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s Global Health Unit (GHU) reached a significant milestone&#58; one million patients</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> have received treatments for non-communicable diseases (NCDs) across more than 40 low- and middle-income countries (LMICs). This progress advances Sanofi&#8217;s goal of treating two million patients by 2030.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The GHU&#8217;s Impact brand, now registered in more than 20 LMICs delivers WHO-essential, standard-of-care medicines on a not-for-profit basis, spanning diabetes, cardiovascular disease, and mental health.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Through partnerships with local governments, non-governmental organizations, and communities, Sanofi has trained more than 27,800 healthcare professionals and community health workers, reaching over four million beneficiaries through NCD programs covering prevention, screening, treatment, and patient management.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The GHU&#8217;s Impact Fund scales inclusive, sustainable ventures that enhance access to affordable, quality care in underserved areas, combining digital innovation and on-the-ground delivery. To date, $9.6 million has been invested in seven early-stage companies, indirectly benefiting an additional ten million patients.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Improving access to affordable medicines in the US</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi in the US has announced a broad expansion of its Insulins Val</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">you</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> Savings Program, first created for people without health insurance, to all patients in the US, regardless of insurance status. This includes those with commercial insurance or Medicare (a federal health insurance program for people aged 65 or older and younger people with disabilities). Effective January 1, 2026, the program will cover all Sanofi insulins, reinforcing the company&#8217;s longstanding commitment to access and affordability. Under this expanded program, any American with a valid prescription will be able to purchase any combination, type, and quantity of Sanofi insulins for a fixed monthly price of $35.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Resilient Cities, Reimagining Health</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Following the launch of its new sustainability strategy &#8220;AIR&#8221;, Sanofi joined the Resilient Cities, Reimagining Health initiative ahead of Climate Week. This global coalition unites 29 cities across 19 countries, alongside healthcare companies and academic institutions</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, to help cities overcome the growing threats that climate change poses to population health and healthcare systems already strained by aging populations and rising chronic disease rates.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The coalition&#8217;s first report &#8220;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">The Case for Action&#58; The power of prevention to support health in a changing climate&#8221; </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">demonstrates how climate-conscious actions could save 725,000 lives each year, cut healthcare costs by $70 billion, and reduce healthcare-related emissions by 15.6 million tons of CO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:1.19pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">equivalent annually by 2030.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The coalition is now building a blueprint for climate-resilient healthcare systems and co-developing a practical guide to embed health equity and prevention directly into climate action plans, as well as bespoke assessment tools to identify and prioritize local interventions, strengthening investment cases.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">New framework to strengthen nature-related disclosures</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has formally adopted the Taskforce on Nature-related Financial Disclosures (TNFD) framework. TNFD adoption strengthens Sanofi's existing nature strategy, a cornerstone of the company's Planet Care program and reaffirms its dedication to environmental stewardship.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ESG ratings</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s latest ESG rankings&#58;</font></div><div style="margin-bottom:5pt;text-align:justify"><img alt="imagea.jpg" src="imagea.jpg" style="height:197px;margin-bottom:5pt;vertical-align:text-bottom;width:649px"></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Cumulative since 2021.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> The Resilient Cities, Reimagining Health initiative is a two-year partnership between the Sustainable Markets Initiative Health Systems Taskforce, led by </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Reckitt and Bupa, and the Resilient Cities Network, with support from the Yale School of Public Health, Mode Economics, and Sanofi.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">10</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_37"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Q3 and YTD 2025 financial results</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business net income</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;12,434 million in Q3 2025 and increased by 2.3% (7.0% at CER) from &#8364;12,157 million in Q3 2024. In YTD 2025, net sales were &#8364;32,323 million and increased by 5.9% (8.7% at CER) from &#8364;30,517 million in YTD 2024.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;736 million in Q3 2025 and decreased by 10.2% (5.9% at CER) from &#8364;820 million in Q3 2024. VaxServe sales of non-Sanofi products were &#8364;484 million and decreased by 5.7% at CER. In addition, other revenues included sales of Opella products in certain markets (&#8364;125 million), manufacturing services and other (&#8364;67 million), royalties (&#8364;32 million), and supply sales to Opella (&#8364;28 million). In YTD 2025, other revenues were &#8364;2,188 million and decreased by 6.9% (4.6% at CER) from &#8364;2,349 million in YTD 2024. VaxServe sales of non-Sanofi products were &#8364;1,326 million and decreased by 2.3% at CER. In addition, other revenues included manufacturing services and other (&#8364;342 million), sales of Opella products in certain markets (&#8364;331 million), royalties (&#8364;100 million), and supply sales to Opella, etc. (&#8364;89 million).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Business gross profit</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was &#8364;9,815 million in Q3 2025 and increased by 5.3% (10.6% at CER) from &#8364;9,317 million in Q3 2024. The business gross margin was 78.9% and increased by 2.3pp (79.2% at CER, up by 2.6pp). In YTD 2025, business gross profit was &#8364;25,275 million and increased by 8.7% (11.7% at CER) from &#8364;23,247 million in YTD 2024. The business gross margin was 78.2% and increased by 2.0pp (78.3% at CER, up by 2.1pp). Generally, the margin improvements in Q3 and YTD 2025 were driven by portfolio shift towards specialty care and enhanced product mix. Specifically, in Q3 2025, the margin improvement also benefitted from lower inventory write-off.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and Development expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;1,834 million in Q3 2025 and increased by 1.8% (4.9% at CER) from &#8364;1,802 million in Q3 2024, broadly reflecting the underlying activity level. The ratio of R&#38;D to net sales was 14.7% and decreased by 0.1pp (14.5% at CER, down by 0.3pp). In YTD 2025, R&#38;D expenses were &#8364;5,551 million and increased by 8.1% (9.7% at CER) from &#8364;5,137 million in YTD 2024. The higher increase in the YTD period includes a c.&#8364;200 million one-time reimbursement of past ALTUVIIIO development expenses, received in Q2 2024, lowering the comparative period, as well as wind-down costs in Q1 2025 for the discontinued E. coli sepsis vaccine candidate. The ratio of R&#38;D to net sales was 17.2% and increased by 0.4pp (17.0% at CER, up by 0.2pp).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;2,291 million in Q3 2025 and increased by 2.6% (7.1% at CER) from &#8364;2,232 million in Q3 2024. The ratio of SG&#38;A to net sales was 18.4% and stable (18.4% at CER, stable). In YTD 2025, SG&#38;A expenses were &#8364;6,797 million and increased by 4.0% (6.3% at CER) from &#8364;6,535 million in YTD 2024. The ratio of SG&#38;A to net sales was 21.0% and decreased by 0.4pp (20.9% at CER, down by 0.5pp). Generally, the SG&#38;A developments in Q3 and YTD 2025 reflected continued support of launches and newer medicines. Specifically, in Q3 2025, expenses also included the first-time consolidation of Blueprint following the closing of the acquisition in July.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Total operating expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;4,125 million in Q3 2025 and increased by 2.3% (6.1% at CER) from &#8364;4,034 million in Q3 2024. In YTD 2025, total operating expenses were &#8364;12,348 million and increased by 5.8% (7.8% at CER) from &#8364;11,672 million in YTD 2024.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income net of expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was -&#8364;1,303 million in Q3 2025 and increased by 31.2% (39.1% at CER) from -&#8364;993 million in Q3 2024. Income included &#8364;144 million from license-out royalties, etc., including on Amvuttra&#174; (&#8364;69 million in Q3 2024), and &#8364;85 million from divestments of medicines&#47;portfolio streamlining (&#8364;13 million in Q3 2024). The income was more than offset by an expense of &#8364;1,369 million representing Regeneron&#8217;s share of profit from the monoclonal antibody alliance (-&#8364;1,066 million in Q3 2024), -&#8364;101 million relating to other pharmaceutical collaborators (-&#8364;18 million in Q3 2024), and -&#8364;62 million from other (&#8364;9 million in Q3 2024). Q3 2025 included the effect from a court decision on Plavix in France. In YTD 2025, other operating income net of expenses was -&#8364;3,246 million and increased by 34.9% (39.2% at CER) from -&#8364;2,407 million in YTD 2024. Income included &#8364;419 million from divestments (&#8364;215 million in YTD 2024), and &#8364;281 million from license-out royalties, etc. (&#8364;179 million in YTD 2024). Expenses included &#8364;3,696 million from Regeneron&#8217;s share of profit from the monoclonal antibody alliance (-&#8364;2,903 million in YTD 2024), -&#8364;167 million from other pharmaceutical collaborations (-&#8364;5 million in YTD 2024), and -&#8364;83 million from other (&#8364;107 million in YTD 2024).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit from associates</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was &#8364;62 million in Q3 2025 compared to &#8364;38 million in Q3 2024 and mainly included the share of profit related to Vaxelis in the US. In YTD 2025, share of profit from associates was &#8364;139 million compared to &#8364;104 million in YTD 2024 and mainly included the share of profit related to Vaxelis.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Business operating income</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was &#8364;4,445 million in Q3 2025 and increased by 2.7% (8.5% at CER) from &#8364;4,327 million in Q3 2024. The ratio of BOI to net sales was 35.7% and increased by 0.1pp (36.1% at CER, up by 0.5pp). In YTD 2025, BOI was &#8364;9,808 million and increased by 5.9% (9.7% at CER) from &#8364;9,265 million in YTD 2024. The ratio of BOI to net sales was 30.3% and decreased by 0.1pp (30.6% at CER, up by 0.2pp). Generally, BOI in Q3 and YTD 2025 improved due to higher business gross profit, partly offset by increased Regeneron profit sharing and R&#38;D expenses in the YTD period.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net financial expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;64 million in Q3 2025 compared to &#8364;71 million in Q3 2024, reflecting lower net debt for part of the quarter and lower average interest rates. In YTD 2025, net financial expenses were &#8364;191 million compared to &#8364;201 million in YTD 2024, also reflecting lower net debt for part of the period and lower average interest rates.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">The effective tax rate</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was 19.3% in Q3 2025 and decreased from 20.0% in Q3 2024. Generally, the effective tax rate will fluctuate from quarter to quarter. In YTD 2025, the effective tax rate was 20.2% and increased from 20.0% in YTD 2024. Sanofi continues to target an effective tax rate in 2025 which is broadly stable versus 2024 (20%).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Business net income</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was &#8364;3,547 million in Q3 2025 and increased by 4.0% (+9.8% at CER) from &#8364;3,411 million in Q3 2024. The ratio of business net income to net sales was 28.5% and increased by 0.4pp (28.8% at CER, up by 0.7pp). In YTD 2025, business </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> See Appendix 3 for the Q3 and YTD 2025 consolidated income statement&#59; see Appendix 9 for definitions of financial indicators, and Appendix 4 for </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">reconciliation of IFRS net income reported to business net income.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">11</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">net income was &#8364;7,699 million and increased by 5.9% (9.8% at CER) from &#8364;7,270 million in YTD 2024. The ratio of business net income to net sales was 23.8% and stable (24.1% at CER, up by 0.3pp).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Business earnings per share</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(business EPS) was &#8364;2.91 in Q3 2025 and increased by 7.0% (13.2% at CER) from &#8364;2.72 in Q3 2024. The average number of shares outstanding was 1,218.1 million compared to 1,253.0 million in Q3 2024. In YTD 2025, business EPS was &#8364;6.30 and increased by 8.4% (12.4% at CER) from &#8364;5.81 in YTD 2024. The average number of shares outstanding was 1,223.0 million compared to 1,250.6 million in YTD 2024.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Influenza vaccines</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In late September, Sanofi confirmed that representatives of the European Commission (EC) visited company premises in France and Germany in connection with an investigation into influenza vaccines. Sanofi is confident that it is compliant with the relevant rules and regulations and is cooperating fully with the EC.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opella</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">On April 30, 2025, Sanofi and CD&#38;R closed the Opella transaction, creating an independent global consumer healthcare leader. Sanofi retained a significant shareholding in Opella through a 48.2% equity interest in OPAL JV Co, which indirectly holds 100% of Opella. Bpifrance owns 1.8% and CD&#38;R the remaining 50.0%. The transaction was completed on the terms previously disclosed, and Sanofi received net cash proceeds of &#8364;10.7 billion. To aid the ongoing assessment of the value of Sanofi&#8217;s Opella stake, Opella&#8217;s summary financials will be disclosed at Q2&#47;H1 and Q4&#47;FY financial results.</font></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_40"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reconciliation of IFRS net income reported to business net income (see Appendix 4)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In YTD 2025, the IFRS net income was &#8364;8,614 million. The main items excluded from the business net income were&#58;</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Net income from the Opella discontinued operation amounted to &#8364;2,861 million, including &#8364;2,674 million related to an Opella divestment net gain following the loss of control date. </font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">An amortization charge of &#8364;1,238 million, of which &#8364;1,199 million related to intangible assets measured at their acquisition-date fair values (mainly Bioverativ &#8364;447 million, Provention Bio &#8364;155 million, Ablynx &#8364;126 million, Kadmon &#8364;119 million, Beyfortus &#8364;92 million, Blueprint &#8364;90 million and Genzyme &#8364;51 million) and &#8364;39 million related to intangible assets from separate acquisitions, measured initially at acquisition cost (licenses&#47;products). These items had no cash impact.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A net impairment expense of &#8364;228 million linked to research and development projects. </font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A &#8364;57 million step-up inventory amortization from the Blueprint acquisition reported in the costs of sales line.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Restructuring costs and similar items of &#8364;602 million mainly related to redundancy plans during YTD 2025.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Other gains and losses, and litigation of &#8364;57 million.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A financial charge of &#8364;99 million related to the remeasurement of expected future royalty on Beyfortus US sales.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A &#8364;543 million tax effect arising from the items listed above, mainly comprising &#8364;202 million of deferred taxes generated by amortization of intangible assets and &#8364;147 million associated with restructuring costs and similar items.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash flow</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In YTD 2025, free cash flow before restructuring, acquisitions, and disposals amounted to &#8364;6,831 million after a change in net working capital of &#8364;136 million, and capital expenditures of -&#8364;1,288 million. After acquisitions</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> of -&#8364;1,415 million, proceeds from disposals</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> of &#8364;527 million, and payments related to restructuring and similar items of -&#8364;491 million, </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">free cash flow</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was &#8364;5,452 million.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net debt</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After the acquisitions of Blueprint (-&#8364;8,381 million), of Dren-0201, Inc. (-&#8364;539 million) and of Vigil (-&#8364;363 million), the impact of the share buyback of -&#8364;4,128 million, dividend paid of -&#8364;4,772 million, the cash provided by the discontinued Opella business of &#8364;136 million, and the net cash inflow from the Opella transaction of &#8364;10,662 million, the change in net debt was -&#8364;2,285 million. The net debt increased from &#8364;8,772 million on December 31, 2024, to &#8364;11,057 million on September 30, 2025 (amount net of &#8364;8,906 million in cash and cash equivalents).</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shareholder return</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Following shareholder approval at the annual general meeting in April, shareholders received a dividend of &#8364;3.92 per share for 2024, marking 30 consecutive years of dividend increases. Additionally, Sanofi is executing a &#8364;5 billion share buyback program in 2025, with the purpose of share cancellation. As of September 30, 2025, 82.0% of the program had been completed, with the remaining shares to be purchased in the open market during the rest of 2025.</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:18.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.396%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Not exceeding &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non-IFRS financial measure (definition in Appendix 9).</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">12</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.993%"><tr><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Media Relations</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Sandrine Guendoul </font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+33 6 25 09 14 25</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">sandrine.guendoul&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Evan Berland</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+1 215 432 0234</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">evan.berland&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">L&#233;a Ubaldi</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+33 6 30 19 66 46</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">lea.ubaldi&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">L&#233;o Le Bourhis</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+33 6 75 06 43 81</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">leo.lebourhis&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Victor Rouault</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+33 6 70 93 71 40</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">victor.rouault&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Timothy Gilbert</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+1 516 521 2929</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">timothy.gilbert&#64;sanofi.com</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.993%"><tr><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Investor Relations</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Thomas Kudsk Larsen</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+44 7545 513 693</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">thomas.larsen&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Aliz&#233; Kaisserian</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+33 6 47 04 12 11</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">alize.kaisserian&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Felix</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Lauscher</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+1 908 612 7239</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">felix.lauscher&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Keita</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Browne</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+1 781 249 1766</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">keita.browne&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Nathalie</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Pham</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+33 7 85 93 30 17</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">nathalie.pham&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Tarik</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Elgoutni</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+1 617 710 3587</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">tarik.elgoutni&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Thibaud</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Ch&#226;telet</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+33 6 80 80 89 90</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">thibaud.chatelet&#64;sanofi.com</font></div></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Yun Li</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+33 6 84 00 90 72</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">yun.li3&#64;sanofi.com</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">13</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_43"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Appendices</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:10.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.448%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_46" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix&#160;1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net s<a href="#i1ad6dd48956a46558d1fbed48fc1ccda_46" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">ales by medicine&#47;vaccine and geography</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_46" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_52" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 2</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">B<a href="#i1ad6dd48956a46558d1fbed48fc1ccda_52" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">usiness net income</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_52" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_58" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 3</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">C<a href="#i1ad6dd48956a46558d1fbed48fc1ccda_58" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">onsolidated income statement</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_58" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_61" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 4</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reconciliation of net income attributable to equity holders of Sanofi to&#160;business net income</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_61" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_64" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 5</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in net debt and summarized statements of cash flow</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_64" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">21</a></font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_67" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 6</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Simplified consolidated balance sheet</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_67" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_70" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 7</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_70" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">Other operating income net of expenses related to Regeneron</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_70" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">23</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_73" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix </a>8</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_73" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">Currency sensitivity</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_73" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_76" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix </a>9</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_76" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">Definitions of non-IFRS financial indicators</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_76" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Appendix 10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sustainability dashboard</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i1ad6dd48956a46558d1fbed48fc1ccda_82" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">27</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Appendix 11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Opella</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">#</font></div></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">14</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_46"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 1&#58; Q3 2025 net sales by medicine&#47;vaccine and geography</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:23.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.071%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025 </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total sales</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of World</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immunology</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,156&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.2</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.6</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,073&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+27.9</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.9</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">579&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.2</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+41.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare diseases</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ALTUVIIIO (*)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">294&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+81.4</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+70.9</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+64.4</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+308.3</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">242&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.3</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadyme (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+27.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+22.7</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+57.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">161&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-2.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.7</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ayvakit (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-27.4</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-30.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-33.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.2</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+22.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+17.9</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+45.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-19.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-21.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cablivi (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Xenpozyme (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+43.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+39.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+57.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+71.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Qfitlia (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wayrilz (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-44.6</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-46.7</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-46.9</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-46.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-30.8</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sarclisa (*)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+41.2</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+36.0</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+41.3</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+35.3</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+47.1</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.1</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.5</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-50.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other main medicines</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">438&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.9</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+29.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.8</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">149&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.6</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">321&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.9</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">142&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+13.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">223&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">196&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.9</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-18.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-43.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">118&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-2.5</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-10.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rezurock (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-112.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+220.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.3</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+18.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.7</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+17.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-43.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-37.5</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-75.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-71.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others </font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">905&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.7</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-27.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">555&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Industrial Sales</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-21.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-23.2</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-21.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Influenza, COVID-19 (**)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,525&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-16.8</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-20.3</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,038&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.4</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">356&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.6</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-29.4</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beyfortus (**)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">739&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.6</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">389&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-21.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+166.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+526.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Polio&#47;Pertussis&#47;Hib primary vaccines and boosters</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.6</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-20.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">331&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Meningitis, travel, and endemic</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">451&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">314&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,434</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.0</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.3</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,838</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+11.1</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,589</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.8</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,007</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+1.9</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharma launches (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,046</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+57.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+49.6</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">705</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+55.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">183</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+45.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">158</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+82.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Launches (*), (**)</font></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,805</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+40.8</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+34.3</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,114</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+17.2</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+98.2</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">247</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+146.2</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">15</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_49"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 1&#58; YTD 2025 net sales by medicine&#47;vaccine and geography </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:23.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.071%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total sales</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of World</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immunology</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,468&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+22.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.3</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,356&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.4</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,448&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.8</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,664&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.1</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">376&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+29.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.2</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">238&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+44.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare diseases</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ALTUVIIIO (*)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">836&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+90.0</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+85.0</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">703&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+73.0</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">133&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+306.1</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">767&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.4</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">385&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">196&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-2.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadyme (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">587&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.5</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">293&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">206&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+45.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">88&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">524&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-8.2</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">135&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.4</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">346&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+34.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-24.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-26.3</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-26.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-33.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">252&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.4</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">134&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">242&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.1</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-24.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-26.1</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-22.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-26.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cablivi (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">202&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Xenpozyme (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">167&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+50.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+47.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">70&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+73.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+77.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ayvakit (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Qfitlia (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Wayrilz (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-36.5</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-37.9</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-28.3</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-55.2</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sarclisa (*)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">431&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+28.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.4</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+31.6</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+28.9</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-2.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.7</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-40.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other main medicines</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,314&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+13.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.5</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+40.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">224&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.8</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">481&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,013&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.1</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">181&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">372&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">460&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">696&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">626&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">643&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.4</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+42.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">354&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-18.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">279&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">394&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.6</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">315&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-30.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rezurock (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">377&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.5</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">320&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+200.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">366&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.3</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">312&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.3</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">255&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">238&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.7</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+17.2</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+30.6</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+28.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+100.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-58.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-58.1</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-66.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-80.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others </font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,876&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.8</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">253&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-20.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">857&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,766&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Industrial Sales</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">347&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">336&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+800.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Influenza, COVID-19 (**)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,739&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.9</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-17.2</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,092&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-8.2</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">408&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-19.8</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">239&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-26.2</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beyfortus (**)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,095&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+29.6</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">346&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+229.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">292&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+227.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Polio&#47;Pertussis&#47;Hib primary vaccines and boosters</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,003&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-2.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">525&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">329&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,149&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Meningitis, travel, and endemic</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,060&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.7</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">633&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">274&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32,323</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.7</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+5.9</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16,373</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+14.1</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,733</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.2</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,217</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.9</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharma launches (*)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,790</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">47.2</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,841</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43.7</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">521</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42.6</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">428</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+72.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Launches (*), (**)</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,905</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+43.9</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+40.3</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,318</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+22.0</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">867</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+84.3</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">720</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+114.0</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">16</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_52"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 2&#58; Business net income</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:15.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="9" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</font></td><td colspan="9" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total group</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2024<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">1</font></font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2024</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2024</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,434</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,157</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.3</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,434</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,157</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.3</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">611&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">740&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-17.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56.3</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">736&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">820&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-10.2&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,292)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,600)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(63)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(60)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,355)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,660)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(26.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(29.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(27.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(30.1</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business gross profit</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,753</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,297</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">62</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">210.0</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,815</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,317</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.3</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">78.4</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">76.5</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">78.9</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">76.6</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,834)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,802)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,834)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,802)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,242)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,219)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(49)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">276.9</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,291)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,232)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income&#47;expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,282)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(982)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(21)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,303)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(993)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates and joint ventures<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">2</font></font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,438</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,331</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.5</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4)</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-275.0</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,445</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,327</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.7</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">35.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">35.6</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">35.7</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">35.6</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(834)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(845)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(19.3</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(20.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #330e74;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,547</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,411</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.0</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">28.5</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">28.1</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business earnings&#47;share (in euros)</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.91</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.72</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.0</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font><br></font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Net of tax.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Determined based on business income before tax, associates, and non-controlling interests.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:0.98pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Based on an average number of shares outstanding of 1,218.1 million in Q3 2025 and 1,253.0 million in Q3 2024.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">17</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_55"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:5pt;text-align:justify;text-indent:4.49pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total group</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">1</font></font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-right:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32,323</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,517</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32,323</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,517</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,857&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,092&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.2&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">331&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">257&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28.8&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,188&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,349&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.9&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,045)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,449)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(191)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(170)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,236)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,619)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(28.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(31.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(28.6</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(31.5</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business gross profit</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,135</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,160</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.5</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">140</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">87</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">60.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,275</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,247</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.7</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">77.8</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">75.9</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">78.2</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">76.2</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,550)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,136)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,551)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,137)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(17.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(16.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(17.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(16.8</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,689)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,466)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(108)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(69)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,797)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,535)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(20.7</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21.4</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income&#47;expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,223)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,408)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,246)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,407)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates and joint ventures<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">2</font></font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">139&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income </font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,785</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,247</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.8</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27.8</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,808</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,265</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">30.3</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">30.3</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">30.3</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">30.4</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(191)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(201)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,918)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,794)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(20.2</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(20.0</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,699</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,270</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">23.8</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">23.8</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business earnings&#47;share (in euros)</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.30</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.81</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.4</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Net of tax.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Determined based on business income before tax, associates, and non-controlling interests.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Based on an average number of shares outstanding of 1,223.0 million in YTD 2025 and 1,250.6 million in YTD 2024.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">18</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_58"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 3&#58; Consolidated income statement</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.640%"><tr><td style="width:1.0%"></td><td style="width:45.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2024</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">1</font></font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,434</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,157</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32,323</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,517</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">736&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">820&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,188&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,349&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,412)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,663)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,293)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,629)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,758</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,314</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,218</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23,237</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,834)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,802)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,551)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,137)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,291)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,232)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,797)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,535)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">297&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">830&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">726&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating expenses</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,600)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,156)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,076)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,133)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(461)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(401)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,238)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,299)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Impairment of intangible assets</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(180)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(228)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(74)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(172)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(144)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(602)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,204)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Other gains and losses, and litigation</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(57)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(465)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating income</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,623</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,539</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,382</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,307</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(227)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(255)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(588)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(838)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">114&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">298&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">408&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and associates and joint ventures</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,510</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,415</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,092</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,877</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(680)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(684)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,391)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,063)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;(loss) of associates and joint ventures</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income from continuing operations</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,828</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,804</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,784</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,865</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income from discontinued operations</font></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,861&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">242&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,808</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,844</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,645</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,107</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,802</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,815</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,614</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,061</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average number of shares outstanding (million)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,218.1&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,253.0&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,223.0&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,250.6&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic earnings per share from continuing operations (&#8364;)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.32</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.22</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.71</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3.86</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Basic earnings per share from discontinued operations (&#8364;)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(0.02)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.03</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.33</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.19</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Basic earnings per share (&#8364;)</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.30</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.25</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.04</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.05</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Figures for the 2024 comparative periods have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">19</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_61"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 4&#58; Reconciliation of net income attributable to equity holders of Sanofi to&#160;business net income</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.640%"><tr><td style="width:1.0%"></td><td style="width:45.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2024</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">1</font></font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,802</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,815</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,614</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,061</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income from discontinued operations</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(40)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,861)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(242)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">2</font></font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">461&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">401&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,238&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,299&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment of intangible assets</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">228&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(191)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">172&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">144&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">602&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,204&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other gains and losses, and litigation </font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">465&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial (income) &#47; expense related to liabilities carried at amortized cost other than net indebtedness</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">229&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax effect of the items listed above&#58;</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(159)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(175)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(543)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(752)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Amortization and impairment of intangible assets</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(84)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(106)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(257)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(154)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(14)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(28)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(19)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(15)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(15)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(34)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(34)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(147)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(377)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(12)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(33)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(96)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(202)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other tax effects</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,547</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,411</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,699</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,270</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business earnings per share (&#8364;)</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.91</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.72</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.30</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.81</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Basic earnings per share</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> </font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364;)</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.30</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.25</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.04</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.05</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Of which related to amortization expense generated by the intangible assets measured at their acquisition-date fair values&#58; &#8364;450 million in Q3 2025 and </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#8364;387 in million in Q3 2024.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Based on an average number of shares outstanding of 1,218.1 million in Q3 2025, 1,223.0 million in YTD 2025, 1,253.0 million in Q3 2024 and 1,250.6 million </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">in YTD 2024.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">20</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_64"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 5&#58; Change in net debt and summarized statements of cash flow</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">1</font></font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,699</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,270</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation, amortization and impairment of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,080&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,136&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(796)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(505)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating cash flow</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,983</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,901</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in working capital</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,147)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,288)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,280)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Free cash flow before restructuring, acquisitions, and disposals</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,831</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,474</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Acquisitions of intangibles assets, investments, and other long-term financial assets<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">2</font></font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,415)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(670)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items paid</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(491)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(787)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Proceeds from disposals of property, plant, and equipment, intangible assets, and other non-current assets net of&#160;taxes</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">527&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Free cash flow</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,452</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,615</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Acquisitions<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">3</font></font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,546)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,507)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of Sanofi shares</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">170&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition of treasury shares and related tax effect</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,128)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(302)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends paid to shareholders of Sanofi</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,772)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,704)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(357)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(205)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash inflow from the Opella transaction</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,662</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by&#47;(used in) the discontinued Opella business</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">136</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">233</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in net debt before Opella reclassification to &#8220;Assets held-for-sale&#8221;</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,383)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,690)</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Opella net debt reclassified to held for sale as of December 31, 2024</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">98</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in net debt</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,285)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,690)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning of period</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,772</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,793</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Closing of net debt</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,057</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,483</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font><br></font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by&#47;(used in) continuing operating activities</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,118&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,916&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by&#47;(used in) operating activities of the discontinued Opella business</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;text-indent:49.6pt;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">354&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by&#47;(used in) operating activities</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,305</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,270</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by&#47;(used in) continuing investing activities</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10,937)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,822)</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by&#47;(used in) investing activities of the discontinued Opella business</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(73)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash inflow from the Opella transaction</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,657&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by&#47;(used in) investing activities</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(316)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,895)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by&#47;(used in) continuing financing activities</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5,589)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,780)</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by&#47;(used in) financing activities of the discontinued Opella business</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(48)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by&#47;(used in) financing activities</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(5,637)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,815)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impact of exchange rates on cash and cash equivalents</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(27)</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash and cash equivalents reported as held for sale as of December 31, 2024</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">167</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,465</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(467)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash and cash equivalents, beginning of period</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,441</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,710</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash and cash equivalents, end of period</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,906</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,243</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">operation.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Free cash flow includes investments and divestments not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">transaction).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Includes transactions that are above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">21</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_67"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 6&#58; Simplified consolidated balance sheet</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:19.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">liabilities and equity</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Equity attributable to equity holders of Sanofi</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">73,263</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">77,507</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Equity attributable to non-controlling interests</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">270</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">350</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total equity</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">73,533</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">77,857</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Long-term debt</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">11,700</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">11,791</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Property, plant, and equipment &#8211; owned assets</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">9,698</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">10,091</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current lease liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,566</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,645</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Right-of-use assets</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,483</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,510</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current liabilities related to business combinations and to non-controlling interests</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">579</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">569</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Intangible assets (including goodwill)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">68,867</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">66,013</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current provisions and other non-current liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">7,004</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">8,096</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current income tax assets</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">552</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">560</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current income tax liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,660</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,512</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Other non-current assets, investments in associates and joint-ventures and deferred tax assets</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">15,152</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">12,036</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Deferred tax liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,647</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">2,166</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current assets</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">95,752</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">90,210</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,156</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,779</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Accounts payable and other current liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">22,000</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">21,792</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Current liabilities related to business combinations and to non-controlling interests</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">0</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">72</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Inventories, accounts receivable and other current assets</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">24,501</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">20,934</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Current income tax liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,614</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">697</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Current income tax assets</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">497</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">724</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Current lease liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">287</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">261</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">8,906</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">7,441</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Short-term debt and current portion of long-term debt</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">8,202</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">4,209</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Assets held for sale</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">138</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">13,489</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Liabilities related to assets held for sale</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">2,131</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current assets</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,042</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,588</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current liabilities</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32,105</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29,162</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">129,794</font></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">132,798</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total equity and liabilities</font></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">129,794</font></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">132,798</font></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">22</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_70"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 7&#58; Other operating income net of expenses related to Regeneron </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Monoclonal antibody alliance</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income and expense related to profit&#47;loss sharing</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">(3,962)</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">(3,069)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional share of profit paid by Regeneron related to development costs</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">787</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">618</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regeneron commercial operating expenses reimbursement</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">(521)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">(452)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total&#58; monoclonal antibody alliance</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,696)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,903)</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Regeneron</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total others related to Regeneron (mainly Libtayo</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and Zaltrap)</font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">107</font></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">130</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #330e74;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total related to Regeneron</font></td><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #330e74;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,589)</font></td><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #330e74;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,773)</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">23</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_73"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 8&#58; Currency sensitivity</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">2025 net sales and business EPS currency sensitivity</font></div><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:55.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Variation</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales sensitivity</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business EPS sensitivity</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US Dollar</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.05 USD&#47;EUR</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-&#8364;968&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;-EUR 0.18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5 JPY&#47;EUR</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-&#8364;55&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;-EUR 0.02</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.2 CNY&#47;EUR</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-&#8364;69&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;-EUR 0.02</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.4 BRL&#47;EUR</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-&#8364;53&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;-EUR 0.01</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Currency exposure on Q3 2025 sales </font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.794%"><tr><td style="width:1.0%"></td><td style="width:84.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.252%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US Dollar</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56.2</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Euro</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.6</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.4</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canadian Dollar</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">British Pound</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">South-Korean Won</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexican Peso</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkish Lira</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.9</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.9</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Currency average rates</font></div><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:55.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.232%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2024</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;$</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.099&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.168&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+6.3%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;Yen</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163.727&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">172.290&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+5.2%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;Yuan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.876&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.365&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+6.2%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;Real</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.095&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.366&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+4.4%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;Ruble</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98.161&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94.158&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">-4.1&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">24</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_76"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 9&#58; Definitions of non-IFRS financial indicators</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Company sales at constant exchange rates</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">References to changes in net sales &#8220;at constant exchange rates&#8221; (CER) means that it excludes the effect of changes in exchange rates.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The effect of exchange rates is eliminated by recalculating net sales for the relevant period at the exchange rates used for the previous period.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation of net sales to company sales at constant exchange rates for Q3 and YTD 2025</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,434</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32,323</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of exchange rates</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(578)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(864)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Company sales at constant exchange rates</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,012</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,187</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Business gross profit</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business gross profit is a non-IFRS indicator that fully excludes from gross profit under IFRS the effect of the release of the fair value step-up to inventory that is recognized upon acquisition which constitutes a business combination under IFRS 3 &#8216;Business combinations&#8217; or which is part of a group of assets as per IFRS 3&#167;2b.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Business net income</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi publishes a key non-IFRS indicator. Business net income is defined as net income attributable to equity holders of Sanofi excluding&#58;</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">net income from discontinued operations,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amortization of intangible assets,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">impairment of intangible assets, </font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">fair value remeasurement of contingent consideration related to business combinations or to disposals,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">expenses arising from the impact of acquisitions on inventories,</font></div><div style="padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">restructuring costs and similar items (</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">comprising transaction, integration, and separation costs in relation to major acquisitions and disposals)</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">other gains and losses (including gains and losses on disposals of non-current assets</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">costs or provisions associated with litigation</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">financial (income)&#47;expense related to liabilities carried at amortized cost other than net indebtedness, </font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">tax effects related to the items listed above as well as effects of major tax disputes,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the share of profits&#47;losses from investments accounted for using the equity method, except for joint ventures and associates with which Sanofi has a strategic alliance,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">net income attributable to non-controlling interests related to the items listed above.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Free cash flow </font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Free cash flow is a non-IFRS financial indicator which is reviewed by management, and which management believes provides useful information to measure the net cash generated from Sanofi&#8217;s operations that is available for strategic investments</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (net of divestments</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), for debt repayment, and for capital return to shareholders. Free cash flow is determined from the Business net income adjusted for depreciation, amortization, and impairment, share of profit&#47;loss in associates and joint ventures net of dividends received, gains and losses on disposals, net change in provisions including pensions and other post-employment benefits, deferred taxes, share-based expense, and other non-cash items. It comprises net changes in working capital, capital expenditures and other asset acquisitions</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> net of disposal proceeds</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and payments related to restructuring and similar items. Free cash flow is not defined by IFRS, and it is not a substitute measure for the IFRS aggregate net cash flow in operating activities.</font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Reported in the line items Restructuring costs and similar items and Gains and losses on disposals, and litigation.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Amount of the transaction above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">25</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_79"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation from net cash provided by&#47;(used in) operating activities to free cash flow</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD 2024<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">4</font></font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;letter-spacing:-0.005em;line-height:100%">Net cash provided by&#47;(used in) operating activities (IFRS)</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;letter-spacing:-0.005em;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,305</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,270</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net cash provided by&#47;(used in) operating activities (IFRS) of the discontinued Opella business</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(187)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(354)</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition of property, plant, and equipment and software</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,288)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,280)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of intangibles assets, investments, and other long-term financial assets</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,415)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(670)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from disposals of property, plant and equipment, intangible assets, and other non-current assets net of&#160;taxes</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">527&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repayment of lease liabilities</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(184)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(206)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">694&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">257&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;letter-spacing:-0.005em;line-height:100%">Free cash flow<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">6</font></font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,452</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,615</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Most directly comparable IFRS measure to free cash flow.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non IFRS indicator (see definition in Appendix 9).</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">26</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_82"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 10&#58; Sustainability dashboard</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The KPIs below indicate progress on the new sustainability strategy.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:16.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.329%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Topic</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ambition</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Progress</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Access to healthcare</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9M 2025</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">H1 2025</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Access diabetes</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increase patient reach by expanding access to diabetes care programs </font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diabetes care programs in three countries (excl. GHU countries) <br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52,143 patients treated</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diabetes care programs in three countries (excl. GHU countries) <br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38,579 patients treated</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">GHU</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reach 1.5 million NCD patients by 2026 (cumulative since 2022) and 2 million by 2030</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">316,095 patients treated in 31 countries<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83 active healthcare partnerships in 29 countries<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eight investments signed through the Impact Fund</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171,666 patients treated in 29 countries<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">83 active healthcare partnerships in 29 countries<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Seven investments signed through the Impact Fund</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Global access plans</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Develop a global access plan for all new medicines&#47;vaccines to make them available within two years after first launch</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12 global access plans initiated or developed covering more than 15 indications</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12 global access plans initiated or developed covering more than 15 indications</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Environmental impact</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">1</font></font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q2 2025</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Climate change &#8211; carbon footprint Scope 1 and 2</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(CO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:0.98pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">emissions)</font></div></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55% reduction in scope 1 and 2 greenhouse gas emissions (GHG) (CO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:0.98pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> equivalent) by 2030 (cumulative vs 2019 baseline) to contribute to carbon neutrality by 2030 and net-zero emissions by 2045 (all scopes)</font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47% GHG reduction vs 2019</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45% GHG reduction vs 2019</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Climate change &#8211; carbon footprint Scope 3</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(CO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:0.98pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">emissions)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30% reduction in scope 3 greenhouse gas emissions (CO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:0.98pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> equivalent) by 2030 (cumulative vs 2019 baseline) to contribute to carbon neutrality by 2030 and net-zero emissions by 2045 (all scopes)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14% GHG reduction vs 2019</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14% GHG reduction vs 2019</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Renewable electricity</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100% of renewable electricity at all sites by 2030</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85%</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eco-design</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20 top-selling medicines and vaccines following eco-design approach by 2030</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50%</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2025</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Blister-free syringe vaccines</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100% blister-free syringe vaccines by 2027</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Data updated annually, next update in Q4 2025</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55% blister-free syringe vaccines</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Resilience of healthcare systems</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q2 2025</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Patient care pathways</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Assess CO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:0.98pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> emissions for the patient care journey for launches across global business units</font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2 patient care pathways analyzed for new launches </font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2 patient care pathways analyzed for new launches </font></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:0.25pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fundamentals </font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2025</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q2 2025</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Global gender representation</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Women in senior leadership roles</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47%</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46%</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Women in executive roles</font></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44%</font></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">End.</font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> As of 2025, Sanofi&#8217;s environmental reporting excludes Opella data.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">27</font></div></td></tr></table></div></div></div><div id="i1ad6dd48956a46558d1fbed48fc1ccda_88"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-looking statements</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words &#8220;expects&#8221;, &#8220;seeks&#8221;, &#8220;targets&#8221;, &#8220;goal&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221;, &#8220;intends&#8221;, &#8220;estimates&#8221;, &#8220;plans&#8221; and similar expressions. Although Sanofi&#8217;s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, political pressure to provide beneficial pricing in the United States including to State Medicaid programs of &#8220;most favored nation&#8221; drug prices and elsewhere, Sanofi&#8217;s ability to benefit from external growth opportunities, to complete related transactions and&#47;or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; in Sanofi&#8217;s annual report on Form 20-F for the year ended December 31, 2024. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">With respect to any sustainability or environmental, social and governance (ESG)-related information contained herein, in light of the significant uncertainties inherent in such statements and other related information contained herein, investors should not regard these statements as a representation or warranty by Sanofi or any other person that Sanofi will achieve its goals, objectives, aspirations, metrics, plans or targets in any specified time frame or at all, including with respect to ESG and sustainability matters, and such statements and other information are dependent on future market factors, such as customer demand, continued technological progress, policy support and timely rule-making or continuation of government incentives and funding, and are forward-looking statements. Sanofi&#8217;s ability to achieve goals, objectives, aspirations, metrics, plans or targets in any specified time frame or at all, including with respect to ESG and sustainability matters, is subject to other conditions and considerations, both within and outside Sanofi&#8217;s control, that may affect its ability to meet such goals, objectives, aspirations, metrics, plans or targets, and&#47;or put in place the initiatives required to meet them. Such conditions and considerations include but are not limited to the risk factors described above. In addition, historical, current, and forward-looking environmental and other ESG or sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future, including future laws and rulemaking. Sanofi plans to continue to evaluate its goals, objectives, aspirations, metrics, plans and targets and its approach to them and may make adjustments as it deems necessary in light of such considerations.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All Sanofi trademarks mentioned in this document are protected.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q3 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">28</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>fsridynmyoja6nzkxmdjmzjnhza.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fsridynmyoja6nzkxmdjmzjnhza.gif
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M9FD1DEANF5"4;J5DY(==WJ6@E[V)>6.:A:D$9G)N/F?GG7CFJ>>>?/;IYY^
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C(,B(%EF.&$E5:Z,Y5$A<'$E@-%F3-GF3. >9DSKI6 $! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>imagea.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 imagea.jpg
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MBWLB  L(#B@.: W4#HP/+ ]\$&06E!%4$]0=[!H\(_A$""$D+&1%R"V>$4_
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M V>YOG.GLA#AV6"SX&M:;AKX-T5U)OW![Z$M4*JZ@*'MOP!"Z8-"4/(_20
M )9E6$EF34T *@    @ !0$2  ,    !  $   $:  4    !    2@$;  4
M   !    4@$H  ,    !  (  (=I  0    !    6@        "0     0
M )     !  .2A@ '    $@   (2@ @ $     0  !_R@ P $     0   FX
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MA6"# $@T\+]D5;WE;N]7C5OOW?_W?3<6,D%)!$1 !$1 !$1 !$1 !$1 !$1
M!$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1@21&(+ZG>JK,B( (B( (B( (B
M( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( *.@ 1__2&(@ B(
M@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(P!(D(,%_
M"7YIZK((B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (
MB( (2/#7WX (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (
MB( (B( (+$$"$OR7X)>F+HN "(B "(B "(B "(B "(B "(B "(B "(B "(B
M"(B "(B "(B "(B "(B !'_]#8B "(B "(B "(B "(B "(B "(B "(B "(B
M"(B "(B "(B "(B "(B "(C $B0@P7\)?FGJL@B(@ B(@ B(@ B(@ B(@ B(
M@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ @DA$ $1$ $1$ $1$ $1$ $1$ $
M1$ $1$ $1$ $1$ $1$ $1. <$ A#A*TF*P[YBKD&8C%^NLVV/UYTV.4(V]LQ
M9G>;5JR3VE4$\19\M'@T[OZST^UB_(PC%MJK?40N?QUZ^A0!$1 !$1"!"Y:
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M1.""("#!_X+X&G41(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "9TR
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M&_PX@O)>/D#S@#VLQ[E&'T, QI(9[J>XGZ+EO'ZJ3\U39T5 !$1 !$1 !$1
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MWX7Z#RA*-6,MQ!,,]T\!*=?%\/K, X;]#QKTZ&2YO?OW4>RA@,2\"?Z7IH%
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M]/JGR0+;H+^I]<T\/1EIP+Q/+:Q_S:]2V*<!0IP&"^Q+BR)0S$M2((O1PS-
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M8;+,I)(WUV=^LV=U=$1_ZOT2_=_2UZ9"(B "(B "(B "(B "(B "(B "2Y-
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M7T)0GZ A0,7EB]IZ*^U9_^RAGIX$U2/<I*6_A?>G5X"2"(B "(B "(B "(B
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M3&K;*O[L7()J$0$1$ $1$ $1$ $16.($G)SDU&UWY\BKB10?"V XQ*4  $
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MCL=#S-1#-.C6GZ 01=G*A?&WLJT%S]^^>=O3$*#1,"G'# -,+*K2"(#M<*D
MOYFA-VJ*)5(4I7B6GOMQBOZ,+4!AGY[TWA0]-AO()3+T.DTSG+Y'(X$<Q7X:
M&M! 8+940E^?+3G ];6YK%^=U@-V;\V8 FR';5*8MX9=B&8*^A99P/<;+@*
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M,L@R2F=?+_/$6*9<XF\"/?:;%-^;24R.,5^=BCL%'A^3Z.ZCYSW+34U5: !
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M.V#1!N8G0%VQ"^C-1G_-*"[\0LWH),GGG &,87>L'T].);&S5,?-PTG<-)S
MVBZ/(<$7EM"V"(C \03<J-(1A>QD6]@Q83Z;IK&[G>.KX==0IT"?I1!3[.Y&
M5ZL;*/FH4/VNE,O(^;P?MO&82[YX-+CQ^(\O3@][C^):C??,61JT]O;TNNK&
MQL=19&06+TGC@*#*^^(,CV<PP]7\:@T*-N$XQ_(Y+.O/<^D6BO:)%AKT]A]:
M,8#2E(W[(8I]P[R7KF&V'#!Z9Q'5V1Z&G.%R+^RC13])I3T7EM^NSXE8T64X
MH:W%WQ_[#6J;&D37R//F/!3-$-AYF@18! #R8(P!1E6AH0.C$:3R1;;!V 3L
M=R*30)[&#$HB( +GEH#=\U6I!?S9GSR YY[9A[__3V[!'9^Z#G?_X$7\X-O/
MX\#.*?CU.I?Y2&!@11&WWK$%O_2Y]] H*(.7GM^'[WW]&3S_Y#Y49NIN3,GW
M9/'N6R[%Y_^W]V!XI8GVT2!H]YBV?,F/OOLL?O3]ES!Z8 9^(_+2M['$C2?,
M&^=S?!_UA0]__ I\\K/OYGVIW0=;'3%\\RM/XEM??0IW?OYZ_(-_>CNFN!35
M?7=MQ</W[\"A/=.H4>@&(Y.8'6SO8!'O_> &_)W?^"!R-![BL(37=HSB]__%
M=U Z7.98FH09?$;1"@(T*'2L6M^+W_Z7'\/E5ZTZVN;++Q[ -[[Z)':\=)A1
M4.R^.KJ>Z(/;-$0P8X4&Q^C/??'=^,7/L\\4X^_]R59\Y4L/HSQ51RIG[40W
M3;:<B45+N?;]:_&[_^H7,##4Y?KVW__X ?S_[+T'8%S7=2;\H0QZ[R Z ;!7
ML8J]BB(IB99DRY8B5\56Y))X'6=C.^ML-LDF7I<D__IW[TVRK$*)*J181;'W
M7D"B$+WW/L  ^WWW88 !40A2I$U9[TK@#.;==^]]9_#.._=\YWSG\-X\?.ZK
MJ_'@HW-0=*T&N[>=P_&#A2B_5@LG,17Y-P)" S!A>@(>?7(.9L\9S_6H]:V)
M,KIXK@2_^^DA%# PHJ.%OE9.K>_8].*K+CF800G3YJ3@T;^8C\P)\=;!(?]J
M3.IH#K"SK!R'2HK-[X9EH6^\(:>\ZP]H??*+^OCD20;PYR]FSG<]K#W '9/
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MOZU"?()T[>!F784^(],SYQ?+@=X;NH*^[W/P&;?I-RZV54)BTU^&W>YN"=B
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M8W1Q'1D(+ITM10!UZ_I-,Y$U.9'XBS PR[,AV0M(5Q"6,)G'/C8/:S=.9VD
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M_P+1R?5!G>%GJ/A5 48L'RK%V=S<B:JJ%H3Z!QEFCE8"_5U= 7PN4,<X_ W
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M/WM!#.;/BL"9LU9-%\_Y' S4*"AN03$W'I75+8B)"*##8O"#6HX04?J?OM"
M@R=K"?:G8\?;A<QPM2+:1"6X[U0U#FTKA9,URJ:212 RW**?]IS+?F]+P);
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M7H!5BP9L.YWT\/US4$Q0_@>_;4%-73/[4R;M7CA\*I]!]=7(&";0@A8;]^#
MDX\L(HO!=,K/\H/<OWP:+O![$^!O-8)Z# 28/BD9G_S0X*"$C2S;<(:, %<*
MJHW<NI@444M6KKJ&-K*"#?V.-9[98_!5S]O(P&XT,^"NCA3^/:S+>WUS,>,8
M<**-"0]Y7;ZH(>A_J:8+\V.],2?!P;( MFOP>IG9O_\Y2T#WB. SA5;Q7X'7
M_!%;B5I"3 (2(A+(T%&(H(  M/EWHC/*!VW,<F]IZ.3^N N!G0%4;R[6F':@
MC: ^>._YN'S0Q3VDRX<L>BS3(EI\S43XG'MP[ATYFU<OWVOO*-U%A$YZ3>&K
M6DL+ZU([?/5<X'E]444J*]?%<E;:\[MH;[H("AFV/GZNO7%[N_:L NU51H!7
MP['=0+]>M9>7?4=E9EZM/:P"#2S=J5?M.?4LZ^SH,.^[9<]R%8HC4(!"!WT$
MZ0EIF#YY&OP9ZB#]I$NPFRT!6P)_' FXG_>\B4><T&+X&;#YAG:T;EII/L\F
M$]&7=E$0[:MWME_!VV]=L:;QO,=Y2@\[*@RIEVQ$W@QH"F#-^^OU@-QCGJ=Y
MSC/:>TL;W\J9HXUZ^XYI95KC8,F-;7R=(_TNT_#:Y2K\K[_=+'5LZ65K8/UB
M!&>8$FFK._A=!+)<F ]]Q':S)7 K$K"M^EN1VGOD'&5#=3.:??^!XWCEM6UX
MY*'UHZY<X,>;VW>CM+P"/J1K'N4Y,N(X9\]?)O5@GE&#%J4K:YVT-.!___/7
M\/0GGR2M=$B_,=D;U\O:TBFLQ[R0M>H_AE_]]CG\V[>_ASAF//SX>]\D^#P0
ME3_2A&7E5?C&=[Y/>N=B^++.E=M1Z2*EK!>O??VJI?C\,Y_"G'MF$BQBQJ<,
M<2I4&;5.&LT7+N7@^S_Z!5Y^]2W6W&*&/YW6G56U6+%\"?[F\T\CD:#,'ZO)
ML3)Y0@2>^% &,R!2L6QI$D%W.HKIKZBN:6-F02GK2Z=AQ9)D.CI\L&MG"3[V
MY"0DC0LV1CP?ZV:I>N#&1 <@BAGY\;'!AJ;?_5U*/MI07+A<QV"'&BQ9D(#U
MJU,91=;,>M3E!- R$4_07_T?>SB;]<,CL6M_F8<CY8\E#7L>6P+O4@+N/_H;
M#6-97_R;UX:W_Q?S7D;9C9J7.4^]>*Y.5[MN;GVL^U/<(CXF'R  ]6W^.'ZQ
M#M-#:Q'DTV8<!;R1:?A93@%K->[Y^];5-T%O3[LFT4Q6XWR^M!YE#.J,ZNIZ
MG&1F_MQ[)L)!G>=/EH!>.@1Z>^@,H).@E\Y4.5156] X&#BG-O<]!+Y=!)_U
MF8*(KC%SZAH=F_I]"<%N ?:Y!-@$P-]SS^Q!->O=2QGI50"_LM\/'CQ$UI08
M?/C#CYD AY'ZNS\7Q7]N;A[JZNH(MD]!4E(2=N_>8Q@#1(<_BR#]6%IL;"RS
MYS<0X+]@ @9>>^UU OZU)N-?90C6K%F#Y.3D04,)\!>EF9P?TIU6  #_*CQV
M->ZW<I(XV?\2P?QR/D/%!+!RY8I!8+][<'?00!5IR?67H4"/EI9F$WPP?GRF
M"3KP8WTUSWG<Y]JOM@3N5@DX:-_%/[R."9HNU/_N9836-J"50+QQHM[F12<N
M6(!NWF_YO_L=&B]=DA>5U*E_W$S_+M*=MC#XJ95E.MJJJYC958ONUA;6;J&.
MU?4R.,&;C"0*1 V*C4$@]5Y(2C)"QB4-+PWJ_U;JA(8<@EX*-I6]>K.-NMK!
M "<_VK+^S+X*(%N)X[H:CC<:4GJGI;P<+0R*ZFYI(7OK3:Y#SS^.X<. !Y7J
M"HB,1""OWS]\ 'SK9,FQ3CX/%,#AQ2 K?[*R.#S*Q-QHC?9Q6P)WJP36KYS&
M_:8?7B%-O>J^*["REPY4 ]P0-6GOZ&56>C6N7JO$^:L5N$@@^)F/KB1]]$#I
MGB7SL@W+4U9:+/8>N8(\CJ':[.XQG%U>*"RMYT\=+N55X@*#"#[[Y/(AV?Y=
M#![-)3/ ZWO.LA8HS[?2O@CXRX+L):W^= +^ Y*L:\E%?6LA=78?(Q[OXR"_
M<4B+7CK0J>^=+-K$B#DH;3P"IZN!@:(Z0!WFK$)C1P&"O</P#M?>16!,'DTO
M!C],FYB$K'1K7RVJ?#793K(QQ\5'F%)4995-W'-VD=&@ED!W*UD01.LOBWB@
M^5.WB/'@I\_MPQ]>/V[JW"M;WY\!H*L63\+??&KU$%GH[+.DR[]ZK8+KL>;6
M>M.3H_' JID#@_>]DQY<O7@R1.5?0XI^HG+LSJ#=R@8&U)<-"_A[\7O.3(W#
M+%+YN\%^#1?"FKII25$\G6-(GW(<E8!82"8 3P8"]=5ZHB+XM^"E[#E^P'5T
M$;AO;S<"5I<1&Z7,[YE@95LCZO,J^!RAO4K9#MOXG7BSYFU#<"0*&)SG/2D$
MV>$Q-N _K+#L#_^<)6#ML*T]M?:^O.6X/Z9NXD]L1 PF9TXD(^8)WD\=" @/
M9*DV >L\SGO9RXM[Q&[NGWD"-1#I^5G^Q-</W<S,[&CC?<62F4+*34!2CV5+
MZ5_+3!+P3U.1\PD LBBP^X)7N0@G P/47$[Z-/F[LC[]Z?_KY#Y=/DPG_9P.
M@FU<"0,!8,IY\J:F*T& ON:PLO2U?U46KEYUC!.9'\_,?\VC.93\9/E(^X!^
M?F[\$CJ7X'XO :C4I%0&4XWCVI4)S  %^2YX7.?;S9: +8&[0P*6]AAY+59P
MD(X/[BG;D+<S;13:9K(;AS2K?R]MBU[JI 6KTC!YYCCJ OO^'R*J43Z0W2M&
M5<G:^J>O,S\P$J8X>VF?IV1$8^'R3#XCK.?'*$-Z'+*^(X\/[+?O8PG8@/^?
M^9>O+/^2FGH\_]+KV+3Q/BKCX12W)83]AX^3UOT C54Z*6FTR7B[V7;I8@Y:
M&IN,M2S#KZNU#?,)MG_L\0\. ?!U7%3%^@E*2<(7/O<9W#-K%GSY\)@R>>(-
MIU9=Y[>V[\*6-W? -RR8VUS^1^783<,XB#1<SSSS,7SQKS]C,DH%J%S?@NB(
MO'?^'$S,RL3*)??BW__S!\AG'>7)!)#^X2M_@QED!?ACMD[29)V[5(>/?& \
MUBY/H=%M/3CK2 _X\]^31C SDED1,61$*.=ZDW#V0@U^_?P5?(J@?W0DJ<,\
M6G_]W+YGK^2B)IE?SJW'&SNO8>G"1 9@^+%\0S/IKC.Q9T\I7GHY#Q]Y+)O9
MK [SX)XY+9:!!F6L-\@ZU'0*Z.%D-UL"[PD)& ?K6%9J&59R1IKFI<VY](4<
MGF/X>U=_TW2>VQ@;>IZ&"F&$YH14)^E2@]#:Z8?O_^H YIROP8I%D\BVD<R(
MVCZ0UYRN?RP=K, #48?JU2@Y4<7V-:EIE?N(CXM$;'0X<KQ+4<J2 #_]]5LX
MQ=J?RQ=/P\3QXXQ30+D#9DQS?=9:^]6\%FB<%YQ+P6+<P!\\?LEDO\?$1.*^
MM6N9C5Z+:]>N&9K[PL*B,0/^ LJ5'2_0?N?.W0:P%R"^9LUJ]V6,^)J;>Y6
M_U7S74R>/)EE"J;CR)$C!,A;<.SX\3$#_GKV39HTD0#\8NJZMQG@=-#,V<%
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M=[:W$?SO18A_"-J9>-1&71'*DB*=]%>*/9/6&>G[.:B> ;S'>VE;2:OTL#R
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MVG7^^,W+AS"7X/ZZ95/[QQ"@/7-RLOFYD6Q=#$)P];;3#A'X0[W%=?@R SS
M,?+^W9<VI)]/D &CC/./^J:'-F57-TN;L)Y\78,RXRU]K S\HZ<+2/-?S,\&
MKG%@71[/"-K*[2P1H ")(8UR:V>&:UX1GRM2-'U9\V)%FI 1QU()24-.T0>J
M0=O2UFEJ3KL["%R/# ]Q_SKD59GY(0RDD$QT%=I7*[-6I16L)HT[N*D>JWP+
MGDWG\7]K7]YWP)L@7\"@DE36 ?6S1#:<C#Q''7AO),SN?!RAHJP%Y85D9B'P
MZ,OR?&KZW-U,<#,_" MV8")]"^OG)6'UK 1$>?@0W'WM5UL"?_82\+@W^J^5
M]X</[V,=$C"3&)O ??!D'+A\ &6EQ60B'8?H\%"T-S<R Y-@/-UONL?;6UOA
M[_1!0&@4O+C'KFRNAH-T_[U,X)%.E1Z1SA:%GLH&**/?V$I\U3$!-K)?C2Y5
M!( 8 >@#4$ 0M0J/ZC]OM-+WYZ"?H$L,'E[^"(\(Y5ZXD?J;P4_B9^$8QGZD
MS<6AC>X1 X'Q3\A'P68%,9FW9NV6+]727:8< ,?0.)8O48,HH<J%C/$9+ <S
MFUP&#-IB&8,> 8'4]2H]:C=; K8$WML2,+8";V7IJ_CX:$QDZ:<@V@HF4&BX
M2^,)GC;K<%U&^TSZR>B\T3J-]9BEIL;:^T_:3WHUB&40)D])0@ #+4>4+U>I
MH,T!<'WPLJW2#7JJT#9U*?A+;#!2UW=:'S.I5W\D;'HFW>G9!E^U_=O-2L &
M_&]68N^1_M0CLN:,DI SM+2Z!B]N?A/K5B^_KN:Q=4&'CC"[?P\!!_95]*B
M$-.H-6[F)NYR4YF:DV6(TC#EQOSZS:\U^-!_?1DI-I;FHN/US)GSV'_T!%0[
MUMI,TS"ELIL_]Q[\MR\\?4.PWW,>U7C>N'X-IDZ9Q(S+.,,ZX'G\3K_7]Z5,
M?L5*1$5847(==';\84NNR;9_D%3^?@[6[&('7:LV(,&LL[=V>3)>WU'(?LS,
MWY3)C/T!T/_Z-9=6M)+!H0@9J:',[A]G'AX:1TVTC]&1OOC IO%XX<4\O/I:
M@0D $%783 8'O/)Z'C<6+AOPOUZH]N]WK00<H:0!-9;K#99HE*7VU"SY0>>?
MKY\_#2=1B$KSW4C[2<<2.*>>$Y#.73ZMKE'.X]X]-=F%K_S53+RQK1Z'3C>@
MIMZ;%)R^.'#X NN>>N,O/]%+BB=V[%4&F%X)R+,^:F\'70'4>VJBU)-^-^MC
M7=&>CEH>#\2<J?&(^\NUV+8S"$=/Y;%F+,>0D_5D#D&;/^!+GW\<$;$A'+H>
M/>W5'(_'N7;-T://6JO0PVP!Z?^<2_DHK:PWT;O3LA-,_5=EV._??P 5S&8M
M*+B&RLHJ0UUO%C7*/S)4V]L[&#"0B77KUA# +R2H?1$OOO@ROO"%SYDYACM=
ME/<*+&AJ:L*T:5.1QLS04-*&SR(3S*E3I\TZ!/S?>^_",3UCM(X$9INN6+$,
MHO37<V3CQ@T,(D@>;OJ;_$S.&V8R\QFHYLM $ >_UQNU5&;@/O744R:80J4*
M2DM+C6XN*RO'M[_]'?S3/_U/*#!"SRB[V1)X+TD@_9F/HI".RMY7R,)46<VL
M :W>LCENYW4D+5YBJ.,O_. '\+Z::^H7W\[Q-9:+ 'SUF3.X^,,?PEE08$"C
M=NH/T:2.]I1P.S.ZJ8?;Z(A57[$ M)"=Y.2IDTA^@$%>'_H00IF!K\>5;'"6
MET8;.;>[>/)H8X]VC6XI"SMTN!@ </(T+IT\A8*L;$QX\DG$SYU#VO^1 Z7T
M'.PFV-=)?=:JP(W1)KO!,:U%Y_LQFZWAX &4'SF,S,<?1];#CR!A[MP;G&T?
MMB7PWI9 , 'C90LFF)\3YZX9&OJ7MAZG_:&[@OM6VG EK!6_[]@5DYD>Q!),
MUS<!/G.FIYN?A];.PJ]>/(B?_V&_*<VDOKT]K-G>I/KR>9@S+959Z;)A;Z[U
M@SOF;N5=R^69I &W,AEF.&/[JJ-G'YU*Q6/MR_M\">9<+^Y;R1@0'&3L-4_
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M<#W>/"Y"P#;:IPX'@PV8%-3!A"M%,;21.<K+JQM^U,DFJ,",SXQ]^DU=*A/
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M'?8++[R(=]YYQV38*X.]B]D*:FXC^M*E2Z:V?1!K4A\Y<@3G6"];34X*K5.
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MVAC@TTM_ (,IN]L::(?21J5Z\V<R5 3WDO4-3? G^ _O0#2V$/AGD+^3 )E
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MN7G(X\_XS/$#PXSAG73^RI4K4%)2BH,'#QK'@YP<[J;WRNR_=JW0')-A7<&
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M3]>PIFRWJ0TXB0_)8$4*V\V6P%TN 3\Z+;N;<BVKK,_('&W)<A+V.!L8H"3
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M3#VQCU-R!MM5T%5G=Q>-=$P3R/VREWQ:C/EV<3#P61$6XL;JI:N)_IH-NC?
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M__.?8=5BIM&C@T5#<R=>VUN"TM-UANPJ\C&? ,OGY^"6;0N'IW!Y#P(6.,%
MXN0JBN=3)2WHXF]E#Q9G#Q^6$J7OEI7I6, ]1 31PL:P[PEZTZ<U!30%SJ$
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M_$4HDQMFPB+7^&*NNX'N:EC#9F"PHX0[^SZ>'WM7C-,)%87H:\! TYN$K-[
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M1TK+<)S&_]_M.X3W/_R(^0 YA^ 0Q>Z$"5M#@O'L\[NP9^][6+URZ2AJBE-
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MZ^M ?#3"*,O9R=O\P>(71!9!FTI=M0IY7[@/]LPLQ' ,D>DN1PG)3$7:-[Z
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M+3YZ[SU".[5@+F'^;SQ/P_A4HS71*^M?__U[6+!@ 6[=N7VJZL/7JVOK>1S
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M,+#JIFMOH#$G"(\__3#JJDL1;O,BS#F /@85#?401<E:2YUE$.4C+VKJJNF
M.0 'C?!]C+JOJJFD/B^$^KL@N"/#B' Z2#VH"\UTKI30)XMC$%X:OJS]/G11
M)]'>,XCLE'2TUC1@[J*51,;R(,C&R'RK&ZG)40@JJ4)C<QM>?>T-B#-N5'0L
M:FN;J&]PP3I -*ON7B(M.;!VU0;<L?UV9*9D4O;U\1R#BX:8O(!&*_]"U6KU
MFZ: IH"FP,520/;3PC\]-)RW=O80\83Z6?(<,U6>1.(/B5.YSXEN1N]+$<<J
MB?#O[NK&V]5GT4"GI/;>'ISM:$=OKZ2+,U6T0^CC\7$:R1]AOT'LMS N1O71
M/>"#.!FT,[7)STI/X>7J6M0R0K^YB\Y5,J9,C"\97YP$:GJ[\5/O$80SS>"L
MJ&BR?\Z:_W]QJA0OG3J-/CH(B*[ 2B<NX^&@AE%OXL35:[?A,<Y1]L [LB7X
M:@CUG']K1QLZG;UXN+0$?S%O/MSL7XJ)-"C/DTZN]3>G3Z*,#@(RZ*F.5FR"
M!(?)6..7WEXO'<V8PH7MK4P5K=8S?M4)SWKY;!DB&K2/\S>*$&7B,2?L2%^X
MHB@PVDIX14U-3^9R4""(@N-V&LFKJRO1V-"$[==OQ8S<G$LV5#]A5K[W@Y_@
M1P\^AI17WD)]?0-VWK 5R2E)DX[1TMR*QW[]6T:\&DQ/N)2%RM7TY 0E2(_7
M."8Z$O?<=B->WK4;#4W-<!"M ))GBLS]0R(8_,T__!O^X(MWXMJ-Z^AQRQS:
MXY2NKB[L?6<??O&K)_#<JV_1@[8/XK#P3__^GS1P!V'=FI54!'\RMXG ^,^:
M$8777J_$N^^=Q=+%2<K6Y@YS8L>6+#S]?#D>>.@8 ^FZ<?AP,XIF1^$&G@_G
M];&EI:T?QTL[,+_80Z$_;-3EM.10W+@M"Z^]78/F0XT8X(9BT-.&G*P(;%B?
M3@%_I/J'^^L0'NI ?!RCD#6_'R&,/KIJ*& +GP%;:!+_QOW04-,P8 N4?7]S
M"3S-'\(9L036GK,8;#_"-8\UE4R##&H\WCS,US?$/@:D'Z((R WE2-I")X#9
M&&CZ@)MK7J>020E77;,R.O^""_NPV-U,"S!;W=O]+2?89\"-/8V.K?9@V,+2
M65/?^-,@EZZB*?"YI4#R3=?!3MFR_H%?(JRR#AW<H,L6\6)*QKIUB@\./?((
MVFGT9PP5#>X7V^OH&<GF.W;5(L0LFT<^:2@5A-\);+\@1@46V3C[J)SP$'K0
MRT@KJ7,UEI[&)N9I-3;RYC9>.+QZT='5&69$D$VU-JDO[44)0PGRG.I>AC)T
MTT?.',-\^D@[<0:P\?F7LG(59MQV^SEM]0E- 4T!30%- 4T!30%-@2N) B+/
MB+ D\J#(-"(GTCT4'NH^E4Q$N<=%'>3F:S80?3,:3SWS$)J;RC!OWEPD1 :A
MEX:E=_?MIRSI0>GQ0ZBJ:J=D:R4B4@_;4R[BOK^WOQN]GAZBC-J5\9\#P,5(
M4Q_UFUXKC5F$D19-J8<. &]_7(J6SEX<.G82N3.*$4M]71OUKE6-5:AIZT,+
MLX'V6X()\^]!0DHBNFGLLC&UH+=/G%<'D!B3C(UK-^*&S3<@TAVNG!;L*C"
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MD%V 17-78DY^,=$'8IBDD/U1=T#@ '_OAEG 7)><-1:JCO2;IH"F@*; I:4
M&:9H+P>X7Q3X> DH%X=THYB?HX>TD4>Z_ [WPU55)+IH.XE03#M&J#AAJ2)G
M G2@/"1+50&F!E<EBS.'D6K\(OQ/G-4=_C$D\M[L06UWI4?RW/ )G 6$:0I+
M#5;7I2618&10%AG*07O7C40V:.CIQ'MG*M' ] ./EIW"[9G9>*6F%N4-]>3M
M-A30<>%6.@:( \3DN@(BNA E8<_K)3CX827M. 8=C-'4L %OQCSZJ1-(SHS!
MS;<O0BB=TI3'VO J%1D4'0(:ZL.KF +:X'\5_WBCIBZ,Q,^DC//&#3VJSOE^
MD2[\#&JDZ<3]+EZT -__CW_"W__+?^"MM]Y!"P5,$53%2TN@^NTT_HM174%9
MD[%+'A4FJ%(&9C%82_31$*^'TY-U^XXM^.K]7Q@9=HHC25/PO7_[-O[Z;_\%
MS^UZ"ST"62H,FF/+R\YQB$LO'-#/_\ARY3]I)M N,JX<AQ%Y8.O&-?IG0BH
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M'[MLV;0A]N57#*(BVIV8B.1UZY&\9#'3Y?2KZ9CKL# ZP<X<M(*DI8NF@*:
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M6'E]PVH: .DYMFMW%9+BZ"$<&XSC-/:?+.O"XB4)6+(X4?4G#[.2TA:\02>
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M1-:V;8@JF#ENA+_T*]%>\D\]-]0HQIM_R( S(X>BBC 4%A;\_^S=!V"4Y?W
M\5]N9.^$!$("A#UD**"("BJ@J'7CGCAJM>Y5;5VMJ]HZ6ZW6;=6Z_==99]VB
M@B![B6P(A)F=W.7^O]][N2.710@))OI]V\N]XWF?]WD_%\G=_9[G]T3K]6(T
M7:OU@:A.3I:L\>,D=]QX2>W=6]QZ#]M;0HYVO?"ZM<@V[$>]+T*V5R/'$4
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M,?U2+:PS,VO@/_SNT]X1VZ)O>H/U.ELM_V&]9BW8GZ8C^].'UF01:'EUG(D
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MY268^JGF;5Y#[]Y:Y7KZSE"S"41Y=0[IK#W$G=13;Z?Q-\FM<DDJ00 !!!!
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M0I26#_8%B)&9LZ;*#3?]62Z^[#(Y]HA#]+AE+PBVPJFJ9G2_<TVKDP4!!!!
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M7!/,UZW(Q3[%VX=>_=)!T_5'>>/U2X@$#>YG252<INW7WO'BCHT\A2T$$$
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M6E^V!OPUJX"^'N;MU?MTOAN)&  1[ R@!U@00  !!!! 8"<%"/CO)""G(X
M @@@X CHAV)/8@\1?41W&:]# 33E7OD&?:S7U0T2*%XE525K=7VS9@;<I(%]
M^SK"/O;JEP\:V'?':#K Z%0-\J=K^K\4?5BP7_<QBM_AY0<""""   ((((
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M_W;WDM @!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$MB]
MP'_[1I1   $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$"@W0D0
M\&]W+PD-0@ !!!!   $$$$   0000  !!!!   $$$$   0000  !!!! 8/L"
M!/RW;T0)!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$VIT
M ?]V]Y+0( 000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!+8O
M0,!_^T:40  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!! H-T)
M$/!O=R\)#4(  0000  !!!!   $$$$   0000  !!!!   $$$$   0000&#[
M @3\MV]$"0000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!-J=
M  '_=O>2T" $$$   0000  !!!!   $$$$   0000  !!!!   $$$$   02V
M+T# ?_M&E$   0000  !!!!   $$$$   0000  !!!!   $$$$   0000*#=
M"1#P;W<O"0U"  $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$!@
M^P*>[1?9^1*YWHD[7PDU((   @@@@  """"   ((((   @@@@  """"   ((
M((   @@@T $%+K_^%+G\AM-:O>6,\&]U4BI$  $$$$   0000  !!!!   $$
M$$   0000  !!!!   $$$$ @*#!J[. V"?9;[03\^2U#  $$$$   0000  !
M!!!   $$$$   0000  !!!!   $$$$"@ PH0\.^ +QI-1@ !!!!   $$$$
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MG5+J[6]HQ_(E:R40"#1TB'T(((   @@@@  """"   ((((   @@@@  """"
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MZ4RY\J93(\YSNYO_LNY(V8B+L($  @@@@  """"   ((((   @@@@  """"
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MU7]_),<<>&6#CR\^^CY4C&<$$$   0000  !!!!   $$$$   0000  !!!!
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M;)-TZIQ6KUEU ^6A AOJ!,QM__:"YJ%S[;EGGUPYY)A]:N_:H?4]]]M-_OS
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M9?<>LYM\\]GLB'UL((   @@@@  """"   ((((   @@@@  """"   ((((
M @BT?X%V&?!?^L,:"00"$6G]]]AK@+SXY/OU1/?<I_X(]97+UD64L[GK?WO*
MG\/[NN5WED_F/"I>[[;;'SMA^ X%_ \_?HS<^_A5$A.S+=A?65DEYYUTBRQ=
MO"9\K75K(E/M9^=$INROFXV@H=3\R9H%X-&7;Y#1^P\-UVLKG[X_36ZZ_*&(
M?;9A3G6M/O]@ANY[3[Y8\(1TSLD,GU-W*H+P 5800  !!!!   $$$$   000
M0  !!!!   $$$$   0000  !!-JU0+M,Z5]15BG+EFP+FIO@"6<<)-U[=8G
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M"""   *[0J M _[M.J5_0[BKEJ^3IQYJ7@K^ALYG'P((((   @@@@  """"
M  ((((   @@@@  """"   ((((   C\'@0X7\#?T&R]_2/YXU4.R>N7Z>J_!
MI@U;Z^UC!P((((   @@@@  """"   ((((   @@@@  """"   ((((   C\W
M@0Z7TK_N"Y"0&">=.J=*985/BK>6RM8M)76+L(T  @@@@  """"   ((((
M @@@@  """"   ((((   @@@@,!/(M"6*?T]/\D=M>)%2XK+I&1Q62O62%4(
M((   @@@@  """"   ((((   @@@@  """"   ((((   @BT?X$.F=*__;/2
M0@000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!-I6@(!_V_I2
M.P((((   @@@@  """"   ((((   @@@@  """"   ((((   FTB0,"_35BI
M% $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$  @;85(.#?MK[4
MC@ """"   ((((   @@@@  """"   ((((   @@@@  """" 0)L($/!O$U8J
M10 !!!!   $$$$   0000  !!!!   $$$$   0000  !!!! H&T%"/BWK2^U
M(X   @@@@  """"   ((((   @@@@  """"   ((((   @@@T"8"!/S;A)5*
M$4   0000  !!!!   $$$$   0000  !!!!   $$$$   000:%L! OYMZTOM
M"""   ((((   @@@@  """"   ((((   @@@@  """"   ((M(D  ?\V8:52
M!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$VE; T[;5B]QU
M\[\DT-87H7X$$$   0000 "!=B40U:Y:0V,00  !!&H+1$F4?D[GDWIM$]81
M0  !!!!   $$$$   000Z*@";1[P[Z@PM!L!!!!   $$$$   0000  !!!!
M  $$?GD"H\8.EM%CAC@W_N6G,V7*)[-^>0C<,0(((-!,@<NO/R5<\NZ;GPVO
MLX(  @@@L.L$"/CO.FNNA  """"   ((((   @@@@  """"   +M7,""_9??
M<%JPE7_Z%P'_=OYZT3P$$/AI!<+_7FHS"/C_M*\%5T< @5^N@*NM;_V*ZT_3
M9('" P-^!_@=X'>@B=^!O77TP*JJ_SJ/ES^X$ZLFK/B;PM]4?@?:]^_ %=JS
MW_X]6ZF/VKW\]3]K%@000 "!GU# 1JO:O\WV>/&#.W["EG!I!!!   $$$$
M 0000  !!!!H38$V#_BW9F.I"P$$$$   0000  !!!!   $$$$   0000  !
M!!!   $$$$   02" @3\^4U   $$$$   0000  !!!!   $$$$   0000  !
M!!!   $$$$"@ PH0\.^ +QI-1@ !!!!   $$$$   0000  !!!!   $$$$
M 0000  !!!! @( _OP,(((   @@@@  """"   ((((   @@@@  """"   ((
M((   @AT0 $"_AWP1:/)"""   ((((   @@@@  """"   ((((   @@@@  "
M"""   (($/#G=P !!!!   $$$$   0000  !!!!   $$$$   0000  !!!!
M ($.*$# OP.^:#09 0000  !!!!   $$$$   0000  !!!!   $$$$   000
M0  ! O[\#B"   ((((   @@@@  """"   ((((   @@@@  """"   (((- !
M!0CX=\ 7C28C@  """"   ((((   @@@@  """"   ((((   @@@@  """!
MP)_? 0000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!#J@  '_
M#OBBT60$$$   0000  !!!!   $$$$   0000  !!!!   $$$$   00(^/,[
M@  """"   ((((   @@@@  """"   ((((   @@@@  """" 0 <4(.#? 5\T
MFHP  @@@@  """"   ((((   @@@@  """"   ((((   @@@@  !?WX'$$
M 0000  !!!!   $$$$   0000  !!!!   $$$$   000Z( "!/P[X(M&DQ%
M  $$$$   0000  !!!!   $$$$   0000  !!!!   $$$"#@S^\  @@@@  "
M"""   ((((   @@@@  """"   ((((   @@@@  "'5" @'\'?-%H,@((((
M @@@@  """"   ((((   @@@@  """"   ((((   AX($$   0000*!A@9R1
MZ<Z!U=]N;+@ >Q%   $5Z#NHN^RQ5S_'8N6R=?+YAS-P^1D)N%PN.>KD_24Z
M.OC1Z:V7/Y>BK:4_HSOD5A!   $$$$   0000  !!!!   $$.K(  ?^._.K1
M=@000 "!-A48<4%?I_[7)T]IT^O4KCRK2[J<./D@9]?<63_*!V]\7?MPH^L>
MKUM&C1DLPT?UE[P>7:1;C\[2N6N&! (B!:LWR-(EJ^7MUSZ7C_\[K=$Z=O1
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MT:M?;KN[_]3T)+GWR2OEV3=O;5:PWV[ LJ-<>>,9,F7Q4Y*2FMCN[HD&M9[
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M;7]G+=C_VG/_"P?\K>Y)IXXGX+\SR)R+  ((((   @@@@  """"   *[5("
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M<&>7X[1CP*O/?!0^S@H""""   ((((   @@@@  """#07@6:'JK17EM-NQ!
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M:&*ORU$G[2\/W_5*1!G;&+9G/QG=2&>%4&'[O7WZ'V^URRPBH3;RC  """"
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MVII:JJL#LK&PX>DYFCJ/8P@@@  """"   ((((   @@@@,"."A#PWU$QRB.
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M-;K[7,5EMY\YGT^,8L&''JTMVM$M.JE%VWHRN,\/CAD0QOTX1_1%0@ !!!!
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M$$6!%.F32<E'\_MTEI;3\G&1<N3.(K4:5+0O-6W<0L>7E%/'+K"/:::U2^<
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M[,!68ST9U]3ZB08$_%U!R".   ((((   @@@@  """1X ?TR=]VPO0F^G=K
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MSR;92V6(\GG>3M#ZM-Z0%:>]%8OTF/;(JM6@HEUN]F\KY-K5&_9V9)EIQFP
MKE-KZ2A_7Z:[BJQ>CB.   )W@T"(T;/W^-'0Y_CYLY?NAEOF'A$(*($31\_(
MKNT'I5C)8/.^W /ZKC>K2Z#HEWVNJ7J=B'OH:V]_:\D//6?9@O6NIY*/!8%6
M_\UVX%YU@Z;W&B-HT]FC%-R/LXT  @@D) ']W?*+#\;*J&]G):1FT18$$$ @
MS@4TR*\O]Z0!MW=Z?2<;5N]T'&K;H;&]/<\(R,=D#6U=[]I]UBBK\F4+-DCO
MKD.M3=X10. N$M"1^N4J%?5XQZN7;957NPSQ>"PF.^/Z>90\>>CRHMIF?SY7
MH_I,CXD9Y]X] @3\[Y[/VF]W6J%3V+1Z?JO4J$CKC6G OVREPI(T:5*[6;Y.
MYV^=L'C..CE[^H)DR9;1W%6A:@GK$.\(((   I$(O/;<YY&4X# """1T@:7S
M-]@!?PWHY\J;U1Q)Y-YNG?[?/>D?K/D+YI)#^X^['Y)[:Y<VUR.U#BQUF6[4
MVL>[_P1T]$!$ ?\4*9)+\\?JR"_#?O??!:D) 000\$'@VI7K7DOI"-03Q\[(
ML9#3<NS(*=$OBG\=\8?<N'[+ZWD<1  !!.)3X*K+LTVGO=?91B-*5RX[CUWU
M4%;+O/S,A]+$F%J_?N.JHL$M3^G.G3LR>\8*Z=_CVW"_KV?-GE$:-KO//FWL
MR(B7W;(+_9<992R?HO?0I&4M*5HBO_MA>UM'O;[WYD\R:=1<>Q\9!! (7('G
MVPXV9M2K+4V-&9J*%,\7X8WJ[W"#W_C!ZZP?-V_>DENW;DORY*'AR8B>F_YZ
M'FG'J.BF*U="SXWN<]4?S_3HMIWS[CX! OYWWV<>XSN>V?GO&-<16Q7,F_6W
M!"4/Z\$:U>O<N?./E,O]>%1/HSP""" 0H4#FK!FD5/F"4J!('N,+S+.R;<,^
M.7KX5(3E[Y8#NF:KF@0%YY#KQGI81P^=DB,'3\J%\Y?O%@+N$X$$*;!D_GKI
M^.(C=MMJU"LO4\:$G_ZS6@2C^:L9'0$\!?RKUREOUZE3@JY;N=W>=LWH,U.G
M*<V6,Y-DSA(ZH]2EBU>,=4./R_[=QT2G*XVMI#-%Z?,Z;_X<QFPE9V3WMD..
M]4ICZ[JQ46_-^N4E5YYL=M4].G\B@X:\(.G2IS'WZ=K8!/QM'C(((!!' @TK
M=HNC*W$9!!! (.X$MF_:[_-WD>^^/D+TY2WI[[M3?UU@OE*F3B'YC+^9<P5E
MD]QYLXE.2WTTQ/@]=?LAXW?C(XXI_%WK;/5D?3N0IAVI%OSN^W>Y^W<?E8_Z
MCS)?^OMQGGS9)7=05G-Y .V8M7=GB/E[\NF3YUTO21X!! )<0)]U^M+G@_[=
MKM_GY35>^FS2 +X^D_;N/"(Z<V!DZ<*YRU(PS4.1%3/J],_S:.P/LT5?,4G1
M?:[ZXYD>DW9S[MTE0,#_[OJ\N5L$$$  @3@2:-JZIO3_Z#D)RI\SW!5UNOOO
MADR4KS^<:*Z!YUI@]?[1DL7XQ5G3]T.GR(?]1KH>-O.5JI60"7,^-//GSUV2
M^PH]+=IAR3TMWC9"\@1E-W=_,G"4?/?)9/<B7K=[#WQ:GOM?:[/,HCEKI%.;
M0>9HWR<Z-9;*]Y64<I6+20ICG2X-TC_5_"UC!$(->:EW6[/\BD4;C7W]'?4G
M39I$6K:O+]W?:!=N*G"KX)Z=AV7:N/DR<=0\.6(L$1"5E"QY4OGVU[YR?Z,J
M]FG3QB^47K$PA9A] 3((!)C RH6;C.?)'7O&I.IURWD,^+M.][]QS2XI7Z68
M*:'E)_S\5S@5U_)_+]LB-V_<=I1Y]XL7I&G+FJ)K\T64CH:<DI^^F6X&JB]=
MO&H7:]:FE@S]\37'Z*>290O*GHO3[3)6YH-^/\F(H=.L37/6@5?Z/FYT<FAA
MS_!D'S0RER]=E???^E%&?C/3=;>9SY QK:S<.\I8IS#T3ZI6]7O)IC6[1=M3
M[\$J4NG>$N:,!S=OWI;?)BV6/MV^L.OX>DP?:=2\NKW=[<GWY:\9*^WMF&9:
M/]G KD+O8<:$Q:)++CSV](/F_BK52TEPX=QR<.\QNQP9!!!   $$$$  @80E
M<./:3=FS(\1\1:5EKM-.3_IEKL?O"WRI[Z0Q:$%?&U;[4IHR""!PMPB<.W-1
M]+5YW9XXN^7X?A[YX[D:W6=ZG"%SH40O0, _T7^$W  """" 0$(2T![X S[K
M*D]V;AIALW1T>Y]!':5V_4KR\M,?RLGCY^RR^@NS%:2O4:^"L3]\P+^9,7V6
M-:U?+F-ZOQK&2,XE?ZVWZ]",KJ]=J&B0O>_DL;!KV#LCR60R1M=:U\F2/9.T
M?ZZ)O/5^%]&UN%V3KMF5)FTJR9@I?5CY;)E<BXA.+_W#Y/[&M(+5'/O=-W1:
ML%YO/R,9,J:3@:]][WXXPNTD29+(EZ->-Z<]M KMWG%(/GSK9VN3=P02K4#Z
MH#12M&ENO[9_]^_'Y%)(6-#<JEP#Z1K KV1TZM&D(_S=DX[TL9XO%R]<D>^_
MF")?C>IC%M.@LGO29T;I"H7MW4L7;K#S5J9:[;)>@_U:3I^-;[[769JVJ"6M
MC>"ZU6E Z[>>559]^NYIGP;IK:0![R]^[BV5JX7>J[7?]5U'Q \>^I(T:UG;
M[-CD.JVT=GARK:]4N8+29V 'J?- 9=<J)+7QR PR1D:YIBS&OP.N[7-_KKJ6
MC6H^=9J4II%UWN]3EXI^L3!E['P[X*_'6AL=L#X;.,8JQCL""""   ((((!
M  A4O*^X%"\5;-_)^)]]G\[?/HD, @@@@( MP'/5IB"3P 4(^"?P#XCF(8
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M>CN-8P@D2@$-^*\;%AI8CZL;6&P\AZR ?[[@7,;S+:<Y3?]]=4([(VD[M%.
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MVN[UU'_^^9?GKE<A#B*   ((((   @@@@  """"   )Q(T# /VZ<N0H""""
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M+IQ;#KIU/O-V/L<00  !!!!   $$$$   0000  !!!*&  '_A/$YT H$$$
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M$G _-T7*9&;Y0L7R2MJTJ>5HR"DYO#_TV>3:D<C]/+812"P"_+Z96#XIVHD
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M!.);@(!_?'\"7!\!!!!   $$$$   0000  !!!!   $$$$   0000  !!!!
M (%H"!#PCP8:IR"   ((((   @@@@  """"   ((((   @@@@  """"   ((
M(!#? @3\X_L3X/H(((   @@@@  """"   ((((   @@@@  """"   ((((
M @A$0X" ?S30. 4!!!!   $$$$   0000  !!!!   $$$$   0000  !!!!
M ('X%B#@']^? -='  $$$$   0000  !!!!   $$$$   0000  !!!!   $$
M$$ @&@($_*.!QBD(((   @@@@  """"   ((((   @@@@  """"   ((((
M @C$MP !__C^!+@^ @@@@  """"   ((((   @@@@  """"   ((((   @@@
M@  "T1 @X!\--$Y!  $$$$   0000  !!!!   $$$$   0000  !!!!   $$
M$$ @O@4(^,?W)\#U$4   0000  !!!!   $$$$   0000  !!!!   $$$$
M 000B(8  ?]HH'$* @@@@  """"   ((((   @@@@  """"   ((((   @@@
M@  "\2U P#^^/P&NCP """"   ((((   @@@@  """"   ((((   @@@@  "
M""" 0#0$"/A' XU3$$   0000  !!!!   $$$$   0000  !!!!   $$$$
M 000B&\! O[Q_0EP?0000  !!!!   $$$$   0000  !!!!   $$$$   000
M0  !!*(A0, _&FB<@@ """"   ((((   @@@@  """"   ((((   @@@@  "
M""" 0'P+$/"/[T^ ZR.   ((((   @@@@  """"   ((((   @@@@  """"
M  (((! - 0+^T4#C% 000  !!!!   $$$$   0000  !!!!   $$$$   000
M0  !!.);@(!_?'\"7!\!!!!   $$$$   0000  !!!!   $$$$   0000  !
M!!!  (%H"!#PCP8:IR"   ((((   @@@@  """"   ((((   @@@@  """"
M  (((!#? @3\X_L3X/H(((   @@@@  """"   ((((   @@@@  """"   ((
M((   @A$0X" ?S30. 4!!!!   $$$$   0000  !!!!   $$$$   0000  !
M!!!  ('X%B#@']^? -='  $$$$   0000  !!!!   $$$$   0000  !!!!
M  $$$$ @&@($_*.!QBD(((   @@@@  """"   ((((   @@@@  """"   ((
M((   @C$MP !__C^!+@^ @@@@  """"   ((((   @@@@  """"   ((((
M @@@@  "T1"XYU\C1>,\GT]9N'"AZ(N$  ((((   @@@@  """"   ((((
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MII'\^?)+[=IU)*+[<&T;>0000  !!!!   $$$$   0000  !!!!   $$$$
M 0000 "!A"N08 /^N_X;M6_1E2L7-B+?VJ?O9<N5=]T4]_,<!__;&#]^G&-W
MW;KUY)Y[[G'LB\K&Q8L79=;OLQRGU*MWO[E]_/AQQ_ZL6;-ZW3Y^[)CCN*>-
MJ+9_Q<KESFK>'RSE#+=I4V=(CNPYG,?80@ !!!!   $$$$   0000  !!!!
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M0S)Q\D1'6[=MWR;KUZ^3^^ZKYGH9\@@@@  """"   ((((   @@@@  """"
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M'56X!_#7K5WK.+[6"+B[IMQ&AP7W%-7VZS(#$:7\^8,=A_[]]U_'-AL(((
M @@@@  """"   ((((   @@@@  """"   ((((   HE#(,$&_/_7O8=#<,'"
M!?+NX$&BT^AKTO=![PZ4A8L6FMO6?[IV[69EY>K5J]*Y2T?Y7X]7[&G\TZ9-
M*Z-'C9%7>[XF&ABW7E:]]LD19'1T?(V:U>3OOU?;)1HU:BQSYLR3X.!@NSXK
MZ%ZI8F7)E"ELB8&MV[;*TF5+S'./'3LJO_TVPZY',_7JW6]O1Z?]>MWL.;-(
MUQ>>DXT;-]A>&MB?.>LWF3!QO%V_9BI6K.C89@,!!!!   $$$$   0000  !
M!!!   $$$$   0000  !!!! ('$(W&,$@F-]B/>52]>CI='E^<XR=NP8Q[DY
M<^8RI_O?MW^?G#AQW'&L5<O6,FKD+_:^AUL\)//GS[.WO65*%"\A:_Y>[ZV(
MK%BY7!YLU%!\)=.V:)O>ZO>F?#[T,[ON-&G22-4J567[]NUR\M1)>W^-ZC5E
MSNRY]G9TVJ\!_XR9T]EUI$R94H*-4?VGSYR6LV?/VOLU4ZID*5FR>+EH&1("
M"""   ((((   @@@@  """"   ((((   @@@@  """" 0.P)I$V?RN^5)_-[
MC7ZL\-.//Y-_C9'\X\:/M6O5(+][H%\/UJ_?0+X?_H-=3C.G3IUR;'O;\"6(
M?^;,&9^#_7HMJ\Z77WI99L_^0[;OV&XV04?N+UJ\R-$<G05@P("!CGW^:/^-
M&S=DU^Y=CGIU(UVZ=#+2Z)! L#\<#3L00  !!!!   $$$$   0000  !!!!
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M$$   0000  !!'P0B(V ?Z*<TM\'*XH@@  """"   ((((   @@@@  """"
M  ((((   @@@@  """ 0T ($_ /ZX^7F$$   0000  !!!!   $$$$   000
M0  !!!!   $$$$   00"58" ?Z!^LMP7 @@@@  """"   ((((   @@@@  "
M"""   ((((   @@@@$! "Q#P#^B/EYM#  $$$$   0000  !!!!   $$$$
M 0000  !!!!   $$$ A4 0+^@?K)<E\(((   @@@@  """"   ((((   @@@
M@  """"   ((((   @$M0, _H#]>;@X!!!!   $$$$   0000  !!!!   $$
M$$   0000  !!!! (% %"/@'ZB?+?2&   ((((   @@@@  """"   ((((
M @@@@  """"   ((!+0  ?^ _GBY.0000  !!!!   $$$$   0000  !!!!
M  $$$$   0000 "!0!4@X!^HGRSWA0 """"   ((((   @@@@  """"   ((
M((   @@@@  """ 0T ($_ /ZX^7F$$   0000  !!!!   $$$$   0000  !
M!!!   $$$$   00"58" ?Z!^LMP7 @@@@  """"   ((((   @@@@  """"
M  ((((   @@@@$! "Q#P#^B/EYM#  $$$$   0000  !!!!   $$$$   000
M0  !!!!   $$$ A4 0+^@?K)<E\(((   @@@@  """"   ((((   @@@@  "
M"""   ((((   @$M0, _H#]>;@X!!!!   $$$$   0000  !!!!   $$$$
M 0000  !!!! (% %"/@'ZB?+?2&   ((((   @@@@  """"   ((((   @@@
M@  """"   ((!+0  ?^ _GBY.0000  !!!!   $$$$   0000  !!!!   $$
M$$   0000 "!0!4@X!^HGRSWA0 """"   ((((   @@@@  """"   ((((
M @@@@  """ 0T ($_ /ZX^7F$$   0000  !!!!   $$$$   0000  !!!!
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M"""   ((((   @@@@  ""!#PYV<  0000  !!!!   $$$$   0000  !!!!
M  $$$$   0000 "!1"A P#\1?F@T&0$$$$   0000  !!!!   $$$$   000
M0  !!!!   $$$$   0+^_ P@@  """"   ((((   @@@@  """"   ((((
M @@@@  """"0" 4(^"?"#XTF(X   @@@@  """"   ((((   @@@@  """"
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M$B !$B !$B !$B !$J# G_< "9  "9  "9  "9  "9  "9  "9  "9  "9
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MJL*D)$ "))"(P--/CY%33CTI4=JXB6 >>ZDE"YOJ;]%B]4A9#_043_??KX_
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M 2#\6:<$*/"O4_PL/!>!,6-&"_[R.0RN(<""H&OAA1?.%]7F5<[YY:T\3Y(
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MM91=:(3%1J5R==T?I=&O)NW32\68Y50^@7CV@2N_O6P!"9  "9  "9  "9
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M$B !$B"!U E0X)\Z4F9( B1  B1  B1  B1  B1  B1  B1  B1  B1  B1
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MD  )D$"5$J# OTHO+)M% B1  B1  B1  B1  B1  B1  B1  B1  B1  B1
M B1  B1  B1  B10W00H\*_NZ\O6D0 )D  )D  )D  )D  )D  )D  )D  )
MD  )D  )D  )D  )D  )D  )5"D!"ORK],*R621  B1  B1  B1  B1  B1
M B1  B1  B1  B1  B1  B1  B1  B1  M5-@ +_ZKZ^;!T)D  )D  )D  )
MD  )D  )D  )D  )D  )D  )D  )D  )D  )D  )D$"5$J# OTHO+)M% B1
M B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B10W00H\*_N
MZ\O6D0 )D  )D  )D  )D  )D  )D  )D  )D  )D  )D  )D  )D  )D  )
M5"D!"ORK],*R621  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1
M B1  B1  M5-@ +_ZKZ^;!T)D  )D  )D  )D  )D  )D  )D  )D  )D  )
MD  )D  )D  )D  )D$"5$J# OTHO+)M% B1  B1  B1  B1  B1  B1  B1
M B1  B1  B1  B1  B1  B1  B10W00H\*_NZ\O6D0 )D  )D  )D  )D  )
MD  )D  )D  )D  )D  )D  )D  )D  )D  )5"D!"ORK],*R621  B1  B1
M B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  M5-@ +_ZKZ^;!T)
MD  )D  )D  )D  )D  )D  )D  )D  )D  )D  )D  )D  )D  )D$"5$FA8
MC>WZ_???9=RX<:%-6W/--:5ITZ:AYQB8'H%;;KE%3CSQ1 'OM]YZ*[V,BY#3
M3S_])*-'C[8Y=^G2I6+OCVIIQ]%''RUWWWVW[+///G+//?<4X8HS2Q(@ 1(@
M 1(@ 1(@ 1(@ 1(@ 1(@ 1(@ 1(@ 1(@ 1(@ 1(@ 1*H#@)5*?#_XHLOI%.G
M3J%7Z*:;;I)CCCDF]!P#TR/PUU]_R1]__"%0OJAK=_/--\N33SXI6VZYI9QQ
MQADUJO/NN^_*_OOO;\-'C1HE.^VT4XTXE1!0+>W ?:-_I>(^:]8L=P\,&#!
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M]H>53DL.850J+ZS0=4:+5-@/H2S>H\V:-;/]-U;$X!U[U%%'64L>.^^\<Q8
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M:JFE,I"MT)% J0G4ZQ7^YD5D';1OX,R#:%>68Z4R3))B%9<1G@M69$-K!_N
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M./)#/'6:!N%F$&17))J!L]76Q6ISK-PW$P@VG3&/GC$36YK4KC@TIHWM.3/
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M/D=Q+'%'K;,?#WVHOJ-Q[V/.\]Y[[_6CT$\")250U3UP;5;XXRK@8Q4/:IC
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M-4V^([8+-8IX=GX5\6!A$%:1U8H69%6P\ H9"AT)U 6!!:!14!<%5V.9&,3
ME ^.,-M$5_\(8((?PFY,1D(PCY<*)CM@=O3++[^T0&"6-,P<6_VCQ1;[!""
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M?:A"+A2K20(D0 (D0 (D0 )E0F#--=<4_)6;X[@VO2O";_?T6#(G$B"!\B-
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MW"Z[[))Y^.&',W_]]9=+XWORI4==[KKK+C^Z]1]WW'&VCD8!.6,FC&N<+T5
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MSM9VO59L\G28O&/W^C777!.=S\L^[S,DWG[LN63EU%;/NEHN;YM5>LG^SUN
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MGNN1AV,]_4:>^K94'R/A@PFSQ#'ISCCCC,!6$V_4?\OE;9_)-./'?CF!U'[
MPM@@G3>]65)8N7K8YWV&Q-M/I6>=E;'2-F^;53K6_ZDMRR*),=<YOXQ%-(!N
M?;[\J[E:UJWB]<S:;RF_(MN )OOI_M7[0CW.WAEJ"?SU++$)4!+(FZL67X)6
ME4V_^.1'BVM;O0=9./71<:<^2E;+CCKJJ+AWL_>+>-]L=B$Z20+61]HUMJU?
MPBH(\_4NEG1ZYMK@G\*K#]5WK4UJ]R:/4]^_+1V]3VM0T(1F:J>:S*CWACPN
MSW,G;Y\5[S^*>M^W/E#O<?H.L'Y?==:D,/F+I\*9:T[_GJ??2WM/S_L\:HV^
MPCAU]FVCWVG;$]]&O1O8_:M[5).>-)%6WWO>''M)EN3T/9[W_2%O^%K7P<J8
MIX])N_>53YI_I6^[O/V4TK>R5N(9_\YN[KM'WOY?Y;,)F_J^SNM,X*^ZZ?E6
M[7?''7>$Y$\]]=3H74OQ9(%)BA,:8]#8;7S,(%X>3490^&K6Q.+AV?^)@)C9
M#R8=DP#C>NECI-;WYOD>-WF8WMLG3)A0UF T>=<FK9Y[[KEEYSB 0"T""/QK
M$>)\LPGH!4D/?&G)ICGKX,P\M<+$3?K'-3@M?IK WZ_M%?*)#\99>&U-6)A7
MX*_\[85%FAE)9R^Y$HQD=?8@0."?E5C'#U?$ &Q\ "U-&"\!N6E<FL6-6G%D
M-LC:?US GG9%)#"6D%#"5L7QZZ5'P>+Y5#+7%@^35OXCCSPRI.O7X(S2C>^8
MZ?H##C@@[MUDOUHYI:6OLLNB0'RPL$DBWF/GG7<.814GS:FO45K2LC=A:DL)
MXS2APZZ;!DWR.I5WRI0I8;#%)C7Y-9"C9"H-2D0!4G;RL/5KZ(7R5])BLP]W
M3?"RB0K5^E4))\VDK5^#N4GI[KWWWHB7+7E1JSVFW4]-$O8>M5C6RB?M'DSC
MKP$AN^8VH2=>'DW&D9!!84XZZ:1PRIZ+&M HTC5R<#1/VY9)=6.2G)2C^JI=
MF!4B]2]R]5R//!SS]AMYZJORMU0?H[QD+4%\-;$SV5\:$UD,D:NG?8:(5?ZD
M;:W\]2%L]ZV"JT^P?DO/(W-YV5N\Y+;:,R3>?BH]ZY+IQ8_K:;.*7ZW_TWF;
M@);U737/H'[:\SJMWRJZ#>B[0==?)O?K<=4$]LGT)&157D.&#(E.67Q]QT@H
M(6:R!G#XX8='UG%J:56/'CTZI*NTT[XQHLP*W"GB?;/ XG3HI$S@+Z&]K J9
MU25=;_W4KM(FMLLJB86);S6)Z(DGGJC*+-X'*:XFJ^B=2N;YL[H\SYUZ^JQX
M&=/ZCWK>]VOU@9K$*QZZ)M5<UOX]K=QI_9[R2A/NY7T>M49?48U39SK7R'?:
M]L:Q$>\&8F#WKRSWI2WGF??](6_X+-?!REAI_"ZMCTF[]Y57FG_:MUVE<E7K
MIQ3'REJ)9U']23W]O\I7E, __GQ,VY>BAIR^@0\]]-!(J2,95I80I>025WQ1
M/+.TE#;6H^_[.^^\,RA]Z!LS_DLJ6BBMSN3B?#M3O3M371G7>S,::XB/D5K?
M6^DYD?8]+DO59HU/"@MQ9Q9>9$$T[7LA'I9]""0)S.P[8QP$&DK FXMR?N:D
MN_'&&YW7^')>X%B6G]=N*#O6@=? C/S\K%[G-;2B8^UX0539L0[\"V?P4WY)
MYU_(G!^,2WIG.O:S>*-P7CLPVK<=KS7HO'E3=_755SO_\NJ\61<[5;;UPB'G
M!:!E?AQ H"4)>*&,\T(8YP>5G1?,9\K:#U!&X3[]]%.G-,SY]<[=Y9=?[NZ_
M_W[G!Q+=M&G3[%38^H_1LF,[\ .<MIMK:_>/_VA+C6?]AG]I*CN?IYQ>LRK$
M]693G1_,+TLG>6!A_<"H\T*4Y&GGM:R"GQ<J.C]QR'ES<DW"-,K#RJ;TO3"D
M9C;^Y2#TT5XKT7E-J- ^DIPK7<^:B?\W@)4I"UNOU1%B^>4'4I/WFF?.6W5Q
MWI*"\X,ZSL_43PUGGEX@Z-27>Z&@2]9+8:SM:%_MQP\(:[>JJW0_%<VRVCT8
M+Z#QE9^>M6G.3WH(WGZP/6R]]HOSED"<UX!P?ND;YRT=./\AXOSR%<["IJ73
MFG[Q>M9JV]:.O)#$K;_^^DV*K7;AEU );=_"-@F4\$B['GDX6OFS]AL67L6H
M5=]$41M^Z+5.G9\\YO0>YP>ZG.YM.;WSJ5W)>0LE81NO1];V&2)6^5/^?_G+
M7\+[G5_#W?W?__U?".TM>#B_;G7HPRU_G; R9&5O?7:>9TB\N/4\ZZP=%MEF
M529KMWJ.MX2S_)27O3L8?_D5T0;\ *V2<GK&-MKY"2TA"Z]]T20K/\G0Z9=T
M7MCO_/JOSEM(2IZ*COT$':=ZZ/GJ)Q.$/MB;(7>#!P]V?C)2%(Z=]DG 6TER
M?FD'YP?RH@KH/CCQQ!.=7T_>>>L;S@_NN?///S^<U_N#%RZ&\WH/\<**\&[M
MEU!Q7K#@O)9K:"?''7=<B!<E&MOQVK'.3XQW?F#0Z1O:#T2&9YQ?&]1YK7+G
M)\K$0J?OQN_56L^=1O19];[OI]?F)U^O2>K..NNLP--;0(GNRWK[][2\TOJ]
MM'#R,\99GT?T%95(XM^>"-2Z1_R$^[+^TNIF]XN.L[P_Y UO^31G6ZF/:4Z:
M%K?>?JH2SZ+ZDT;T_U;G6EMOGM_I&5O-Z?DKIV_:DT\^V>V^^^Y.WPC>PH$;
M-VY<-*:L=S#Y:QS$:]%&XSI>R!;BZWF:='HO]":XD][AV$_H"&-DJ2?QA$ '
M(&!]+.-Z+GS#9;VD]@R,?X]KC-)/$ COZWX91.>5%9R?K"OE;'?!!1>$I+VE
M+F?]4=:\" <!!/ZT@883\.:2@C!< \+>)+7SFC!!@"^AHP:*-1% 3AV:.;]F
M=>CDO'DEY]=M=M[<7Q#6^)FOSIM><GYY  L:Q?-KE >AOS?=[/P,S2#8U(O8
M4T\]%01#?B9^%"?/C@;J-.@F8;\&3;R9<N>U2IV??1R2T4"-UQ@-QWKIN_CB
MBX/@1"<EC'KMM=="/350,VG2I#Q9$Q8"A1/P&KXA34U R>(J#51+0*@7D[AP
M70-TWGQ\&'S7!("BG0WN5THW[7S><FK@3:[2Q)UXWA96 G+]JCGK+ZJ%*?*<
ME<UKN4:#FI72UT>L!+U^3;LHB%XR-7E*\35 K+ZXN<[*E(6M]=<F<$OF;2_+
M\M<@2"V!O\*EM0_YRU4[]U.(]/_D_=0(EI7NP62)C*_\O8GJY.FR8VN/?CUQ
MYZT;A/:K9Z5^<LI3DUB\-D2;$SI9/;.T;6M'>H8G)QL:$!,LZ/TBBTN['GDX
M6OFS]AL6/DM]LY2_R#!^>1/GK1R%28_Z0#6!O_;EO&91>!?3OM5#^UG;I\)6
M<^H?O)EKYS65PON9UZYR$I2;\,QKM99-YK$R9&6OO/,^0ZJ5-\NY1K19Y9O6
M;K.4I]XP:?D9?Z591!OP9L^#P%1"S48Z32BPLDN86LWI'4C?(WXI'^<U_9W7
MZ*X6/ S>2/CKS?:']RE](^DGYY=:"8,^FN"&:Y\$-,DVZ?2^HDGBF@@Z9LP8
MYY<!BH)X[4)WP@DGA&,)Z#4!3T[]G-ZK=]MM-^<U_$/;DG#)6]$+Y^-_FJQJ
M_NNNNZ[;88<=G#<_[]Y]]]W0SNR[.QXGN6_M/<MSIQ%]5JUWLEKGD_71L;VO
M:5_?0!*$%=V_I_5[RB_-&>.LSR,][^@KTDCBUYX(Y+E'XO6R^T5^6=X?\H:/
MYU7O?EH?4V]:\7A%]U-*6X*C(OJ31O3_\;I7V]=WG2:HYW%Z/_,69,)/\:0
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M&HR3QHXT?M2.Y<0X[O*R;XUG74NUV3B71N_;?6+\BVH#-M%+5EZ^_/++5*W
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MW]>/TD,  A"   0@  $(0*!3$M",?;]&9ZC[_OOOWRD94&D(0  "$(  !"
M 0A   (0@  $VA\!4V#0LFZ;;KII^ZL )6YS!"HO M?FBDJ!(  !"$"@&@&M
M57ONN>>&(-K'00 "]1/@?JJ?'3$AT%($9LR8X<X^^^R0W?;;;]]2V9(/!"
M 0BT(0+#AP]W*Z^\LNO?OW\;*A5%@0 $.@H!^IB.<B6I!P0@T-D(M(=QO2%#
MAKC!@P>[ 0,&N*Y=T<WN;&VT$?5%X-\(JJ0) 0A H!4(S#GGG X-QU8 3Y8=
MD@#W4X>\K%2J@Q'HUZ^?TP\' 0A   *=EX#6.]4/!P$(0* 1!.AC&D&5-"$
M 0@TGD![&-?;99==&@^"'#H5 ::-=*K+364A  $(0  "$(  !"   0A   (0
M@  $(  !"$   A"   0@  $(0*"C$$#@WU&N)/6   0@  $(0  "$(  !"
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M3S^]21'R,%'D>O/Q0O.2%[PT*9<W35W2M1+3:Z^]MJQ\1;)56U >:D=9G1>
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M)"LM$Y/F)/#7)#,M)W#EE5>Z__N__PO!-('PDT\^"8)^"?QQ$(  !"   0A
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M@S63:F7D7/$$VN,[;?$42!$"$(! -@+Q[PO$3=F8$0H"$(! T01F+CI!TH,
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M*@\!"$   A"   0@  $(U"+PG__\Q^D7=_/..Z\[Z:23W.:;;Q[W9A\"$(
M!"#0+ ):7N6VVVX+:>R___[-2HO($(  !"   0A   (0@$#G((# OW-<9VH)
M 0A   (0@  $(  !".0DL.***[J77WXYK ^M]>$___SS8+J];]^^81D(+5F
MZWP$A@\?[K2V=O_^_3M?Y:DQ!"#0< (S9LQP9Y]]=LAG^^VW;WA^9  !"$
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M86Z777:I%*15_;_YYALW??KT)I,66K509 X!"$   A"   0@  $(0  "$(
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MKKGF<CUZ]&AR'@\(0  "$(  !"   0A   (0@  $(  !"#27 ";]FTN0^!"
M  0@  $(0  "$(! FR4@<_MQ[?K77W\]F/O_[6]_&X3]??OV===??[V3=O^D
M29/<\\\_[_[\YS\WJS[*4ZY4*H6M'8<#_B   0A   (0@  $(  !"$   A"
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M!/[UDB,>!"   0A   (0@  $(-"N"4BK?L"  >'7Z(HHK^666R[\&IT7Z4,
M A"   0@  $(0  "$(  !"   0AT'@+I]B\[3_VI*00@  $(0  "$(  !"
M 0A   (0@  $(  !"$   A"   0@  $(0*!=$D#@WRXO&X6&  0@  $(0  "
M$(  !"   0A   (0@  $(  !"$   A"   0@ ('.3@"!?V=O =0? A"   0@
M  $(0  "$(  !"   0A   (0@  $(  !"$   A"   3:)0$$_NWRLE%H"$
M A"   0@  $(0  "$(  !"   0A   (0@  $(  !"$   A#H[ 00^'?V%D#]
M(0 !"$   A"   0@  $(0  "$(  !"   0A   (0@  $(  !"$"@71) X-\N
M+QN%A@ $(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $( "!SDX
M@7]G;P'4'P(0@  $(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $
MVB4!!/[M\K)1: A   (0@  $(  !"$   A"   0@  $(0  "$(  !"   0A
M  (0Z.P$$/AW]A9 _2$  0A   (0@  $(  !"$   A"   0@  $(0  "$(
M!"   0A H%T2:+C ?\RD)]LE& H- 0A   (0@  $(  !"$   A"   0@  $(
M0  "$(  !"   0A   (0:,L$&BKPG_CE?]PCDY]VVN(@  $(0  "$(  !"
M 0A   (0@  $(  !"$   A"   0@  $(0  "$"B.0$,%_F,^>BJ4U+;%%9N4
M(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $(  !"$   IV;0,,$
M_M+J?^>K]P-=;='R[]P-C=I#  (0@  $(  !"$   A"   0@  $(0  "$(
M!"   0A   (0@$"Q!!HF\$]J]2>/BZT&J4$  A"   0@  $(0  "$(  !"
M 0A   (0@  $(  !"$   A"   0Z%X&&"/SCVOV&$RU_(\$6 A"   0@  $(
M0  "$(  !"   0A   (0@  $(  !"$   A"   0@T'P"#1'X5]+FK^3?_&J0
M @0@  $(0  "$(  !"   0A   (0@  $(  !"$   A"   0@  $(0*!S$2A<
MX)^FW6](T?(W$FPA  $(0  "$(  !"   0A   (0@  $(  !"$   A"   0@
M  $(0  "S2-0N,"_EA9_K?/-JPZQ(0 !"$   A"   0@  $(0  "$(  !"
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M(\$6 A"   0@  $(0  "$(  !"   0A   (0@  $(  !"$   A"   0@D(]
MLP7^S=72;V[\?-4E- 0@  $(0  "$(  !"   0A   (0@  $(  !"$   A"
M  0@  $(0*!C$&B6P+\YVOV&#RU_(\$6 A"   0@  $(0  "$(  !"   0A
M  (0@  $(  !"$   A"   0@D)U LP3^16GG%Y5.]FH3$@(0@  $(  !"$
M A"   0@  $(0  "$(  !"   0A   (0@  $(-"^"=0M\"]"N]_0H>5O)-A"
M  (0@  $(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $LA&H6^!?
MM%9^T>EEJSZA(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $(  !
M"$   NV30%T"_R*U^PT;6OY&@BT$(  !"$   A"   0@  $(0  "$(  !"
M 0A   (0@  $(  !"$"@-H&Z!/Z-TL9O5+JU,1 " A"   0@  $(0  "$(
M!"   0A   (0@  $(  !"$   A"   0@T+X(S%Q/<8?WV;J>:,2!  0@  $(
M0  "$(  !"   0A   (0@  $(  !"$   A"   0@  $(0* @ G5I^!>4-\E
M  (0@  $(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $(% G 03^
M=8(C&@0@  $(0  "$(  !"   0A   (0@  $(  !"$   A"   0@  $(0* U
M"2#P;TWZY T!"$   A"   0@  $(0  "$(  !"   0A   (0@  $(  !"$
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M^>233M=AU557=4LNN60R*L<0@  $(  !"$   A"   0@  $(0  "$(  !"
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M*:EMI;G__.<_I:%#AS:)HS(KGI7]W'//38N.'P0@  $(0  "$(  !"   0A
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MU[606VZYY<)$@;BP7_X++[RP-C@(0  "$(  !"   0A   (0@  $(  !"$
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M]-%'T6E90?CBBR_"L28%5*M/%(D="$   A"   0@  $(0  "$(  !"   0A
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M^<&#!P=3__W[]P_+&,A2Q*!!@^JI3K/BS#333$WBQRT,S#'''$W.XP$!"$
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M"I'[Y2]_F2KLKU3<+EVZ1*>F3Y\>[3=R)]Z.[KWWWD9F1=H0@  $(  !"$
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M<;HO9-E"5A8T$0 ' 0A   (0@  $(  !"$   A"   0@  $(0  "$(  !"
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M  $(0  "$&@A @C\6P@TV4"@M0AHU8[GGGLN_-+*L/WVV[N]]MHK[11^$(
M!"   0A   (0@  $(  !"$   A"   0@  $(0  "$(! &R: P+\%+LZ""R[H
MEEUVV; >?9<N75H@1[* P/\(''/,,6[LV+'NK;?><E.F3 GML$^?/JYOW[YN
MQ(@1;NC0H?\+S!X$(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $
M(-!N"'3QVK^E=E-:"@H!"$   A"   0@  $(0  "$(  !"   0A   (0@  $
M(  !"$   A" 0"#0%0X0@  $(  !"$   A"   0@  $(0  "$(  !"   0A
M  (0@  $(  !"+0_ @C\V]\UH\00@  $(  !"$   A"   0@  $(0  "$(
M!"   0A   (0@  $(  !-W,]##X\_UCW[81_U1.U:ISNB_=W"^UW;-4PG(0
M!"   0A   (0@  $(  !"$   A"   0@  $(0  "$(  !"   0A P+FZ-/Q[
M#/M-0]@U*MV&%)9$(0 !"$   A"   0@  $(0  "$(  !"   0A   (0@  $
M(  !"$   JU(H"Z!_\_Z#73=%EF\T&(K/:6+@P $(  !"$   A"   0@  $(
M0  "$(  !"   0A   (0@  $(  !"$"@-H&Z!/Y*=NYU?UL[]1PABDXO1]8$
MA0 $(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $(  !"+0[ G4+
M_&=;]E=NE@5[%5)AI:/T<!"   0@  $(0  "$(  !"   0A   (0@  $(  !
M"$   A"   0@  $(9"-0M\"_2Y<N;NZAFV?+I48HI:/T<!"   0@  $(0  "
M$(  !"   0A   (0@  $(  !"$   A"   0@  $(9"-0M\!?R<\Q<'4W\[P+
M9,NI0BC%5SHX"$   A"   0@  $(0  "$(  !"   0A   (0@  $(  !"$
M A"   2R$VB6P+_+3#.Y'D.:I^6O^$H'!P$(0  "$(  !"   0A   (0@  $
M(  !"$   A"   0@  $(0  "$(! =@+-$O@KFSD&K^VZSC5/]AQC(15/\7$0
M@  $(  !"$   A"   0@  $(0  "$(  !"   0A   (0@  $(  !".0CT&R!
M?Y=99G$]UMXD7Z[_#:UXBH^#  0@  $(0  "$(  !"   0A   (0@  $(  !
M"$   A"   0@  $(0" ?@68+_)7=G*NLZ[K.-F>NG!5>\7 0@  $(  !"$
M A"   0@  $(0  "$(  !"   0A   (0@  $(  !".0G4(C OVNW[FZNM3;,
ME;O"*QX. A"   0@  $(0  "$(  !"   0A   (0@  $(  !"$   A"   0@
M ('\! H1^"O;N5;__^W=^[=54__ \97<0^5>+B61(I32A1#Q[5N^@_S@^1_]
M9&@81!1%E!)RET+NBB27<OF>]WR>S[%:S[K,O<\^.M5[CG':>Z_+7'.^UERS
M'SYSSK6R&'=V7@"?XSC>I( ""BB@@ (***"  @HHH( ""BB@@ (***"  @HH
MH( ""BB@@ +]"0PLX#_^G G%Q"7_DU4*CN-XDP(***"  @HHH( ""BB@@ (*
M**"  @HHH( ""BB@@ (***"  @KT)S"P@#^7O^#NU45QQIGM)1G:GXYK/\J]
M"BB@@ (***"  @HHH( ""BB@@ (***"  @HHH( ""BB@@ (**- B,-" __CS
M)A87++JWY7)#@P*&]G.<20$%%%!  0444$ !!1100 $%%%!  0444$ !!110
M0 $%%%!  07Z%QAHP)]B3+SG_XIQIXVO+1';V6]20 $%%%!  0444$ !!110
M0 $%%%!  0444$ !!1100 $%%%! @9$)##S@?_JDBXL)MRVK+17;V6]20 $%
M%%!  0444$ !!1100 $%%%!  0444$ !!1100 $%%%! @9$)##S@3W$FW?MP
M48P;=VS)AGZG[<=N]9<""BB@@ (***"  @HHH( ""BB@@ (***"  @HHH( "
M"BB@@ (*]"$P*@'_,RZ94DRX9<DQQ>$WVTT***"  @HHH( ""BB@@ (***"
M @HHH( ""BB@@ (***"  @HH,'*!40GX4ZR)S/(OI>KOTBZ_*J"  @HHH( "
M"BB@@ (***"  @HHH( ""BB@@ (***"  @HHH$"/ J,6\#]KZK3BW#GS4W'X
MY+=) 0444$ !!1100 $%%%!  0444$ !!1100 $%%%!  0444$ !!08C,&H!
M?XHWZ;XUJ93Q.9@BFXL""BB@@ (***"  @HHH( ""BB@@ (***"  @HHH( "
M"BB@@ (*C&K _ZQIUQ>3_O=?!9\F!1100 $%%%!  0444$ !!1100 $%%%!
M 0444$ !!1100 $%%!B<P+B_AM+@LC,G!1100 $%%%!  0444$ !!1100 $%
M%%!  0444$ !!1100 $%%/@G!$9UAO\_40&OH8 ""BB@@ (***"  @HHH( "
M"BB@@ (***"  @HHH( ""BB@P*DH8,#_5+SKUED!!1100 $%%%!  0444$ !
M!1100 $%%%!  0444$ !!110X(07,.!_PM]"*Z"  @HHH( ""BB@@ (***"
M @HHH( ""BB@@ (***"  @HH<"H*&/ _%>^Z=59  0444$ !!1100 $%%%!
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M+]Q3^A("^_2[D1^# CB7^F#:U<?&]>(SIUY1EJ9GC(%&T9?$)_F7O\?U_%1
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M:FI+\6RW'5/=QTQ^ OX,_&)0 ?TIVR@?J=?[D5LOGIO<1)E,"BB@@ (***"
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MSRH,?!]$.MG:V2!,S./? @PZHGVTK=RAE0(***"  @HHH( ""BB@@ (***"
M @HHH( ""BB@P-@1,. _=NZ%)5%  0444$ !!1100 $%%%!  0444$ !!110
M0 $%%%!  0444"!;X+3L(SU0 0444$ !!1100 $%%%!  0444$ !!1100 $%
M%%!  0444$ !!<:,@ '_,7,K+(@""BB@@ (***"  @HHH( ""BB@@ (***"
M @HHH( ""BB@@ +Y @;\\ZT\4@$%%%!  0444$ !!1100 $%%%!  0444$ !
B!1100 $%%%! @3$C\/] \60 <$%B(     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
